CURRICULUM VITAE

DAVID S BASKIN MD FACS FAANS

PERSONAL

Home Address 1656 North BoulevardHouston Texas 77006-6330

Marital Status Married 3 children

EDUCATION

BA with High Honors Swarthmore College 1974Swarthmore Pennsylvania

MD Mt Sinai School of Medicine 1978New York New York

Intern in Surgery University of California 1978-1979San Francisco California

Resident in Neurosurgery University of California 1979-1984San Francisco California

Research Associate Departments of Anesthetics 1981Clinical Sciences Immunologyand NeurosurgeryUniversity of CapetownMedical School Groote Schuur HospitalCapetown Republic of South Africa

Research Associate Hormone Research Laboratory 1983University of California School of MedicineSan Francisco California

MEDICAL LICENSURE

California License No G40053 1979-PresentTexas License No G7485 1985-Present

SPECIALTY CERTIFICATION

American Board of Board Certified September 24 1986Neurological Surgery (Not Time Limited)

FACULTY POSITIONSPresidential Distinguished Chair Houston Methodist Hospital 2012-PresentDepartment of Neurological Surgery Houston Texas

Director Houston Methodist Hospital 2013-PresentKenneth R Peak Center Brain and Houston TexasPituitary Tumor Treatment Center

Vice Chairman The Methodist Hospital 2007-PresentDepartment of Neurological Surgery Neurological Institute

Professor Weill Cornell Medical College 2007-PresentDepartment of Neurological Surgery New York NY

Research Professor University of Houston 2006-PresentCullen College of Engineering Houston TXDepartment of Electrical andComputer Engineering

Research Professor School of Pharmacy University of Houston 2005-Present

Residency Program Director Houston Methodist Hospital 2005-PresentDepartment of Neurological Surgery Neurological Institute

Adjunct Professor of Neurological Surgery Baylor College of Medicine 2005-PresentHouston Texas

Professor of Neurological Surgery Baylor College of Medicine 1994 - 2005Houston Texas

Professor of Anesthesiology Baylor College of Medicine 1994 - 2005Houston Texas

Associate Professor Baylor College of Medicine 1989 - 1994of Neurological Surgery Houston Texas

Associate Professor Baylor College of Medicine 1993 - 1994of Anesthesiology Houston Texas

Attending Physician Veterans Affairs Medical Center 1991 - 2007Neurological Surgery Houston Texas

Assistant Professor Baylor College of Medicine 1984 - 1989of Neurological Surgery Houston Texas

Assistant Professor Baylor College of Medicine 1985 - 1993Center for Biotechnology Houston Texas

Chief of Neurological Veterans Affairs Medical Center 1984 - 1991Surgery Houston Texas

Attending Physician Houston Methodist Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician Ben Taub Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician Texas Childrens Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician St Lukes Episcopal Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician Memorial Hermann TIRR 1984 - PresentNeurological Surgery

Attending Physician Columbia HCA - Del Oro Hospital 1994 - 1996Neurological Surgery Houston Texas

Attending Physician Texas Orthopedic Hospital 1995 ndash PresentNeurological Surgery Houston Texas

Consulting Physician Johnson Space Center 2012-PresentNeurological Surgery

Special Consultant National Aeronautics and SpaceMonitoring Intracranial Pressure in Space Administration (NASA) 2013-Present

HONORS AND AWARDS

Valedictorian Roxbury High School 1970Succasunna New Jersey

Award for highest Roxbury High School 1970Grade point average Succasunna New Jersey

Phi Beta Kappa Swarthmore College 1974Swarthmore Pennsylvania

Sigma Xi Swarthmore College 1974Swarthmore Pennsylvania

Alpha Omega Alpha Mt Sinai School of Medicine 1978New York New York

James Felt Memorial Mt Sinai School of Medicine 1978Prize Outstanding all- New York New Yorkaround student during the four years of study

Residentrsquos Prize for Federation of Western Societies 1982best scientific paper of Neurological Science

Annual Meeting San Diego California

Academy Award for The American Academy of 1983Original scientific Neurological SurgeryResearch 27th Annual Meeting

Pebble Beach California

Nominee Nominated by Baylor College 1984PEW Foundation Scholars of Medicinein the Biomedical Sciences Houston Texas

Continuing Education The Joint Committee on Education 1986Award in Neurosurgery American Association of Neurological

Surgeons amp Congress of NeurologicalSurgeons

Fellow American Heart Executive Committee of American 1986Association Stroke Council Heart Association Stroke Council

Fellow American College Membership Committee American 1988of Surgeons College of Surgeons

Wakeman Award for Research Wakeman Award Committee 1990in the Neurosciences Duke University

Durham North Carolina

Saul Horowitz Award for the Mt Sinai School of Medicine 1990Outstanding Alumni Achievement New York New York

Named in Whos Who in Medicine Marquis Whorsquos Who in America 1990 - Presentand Healthcare

Selected by Peers to be included in Woodward White Inc 1996 - PresentFirst and Subsequent Editions of the Aiken South CarolinaBest Doctors for America

Elected to Texas Hall of Fame Publishers Plus 1996 - PresentEnglewood New Jersey

Named in Whorsquos Who in Medicine International Whorsquos Who 1997 - Presentand Healthcare of Professionals

Named in Whorsquos Who in the South Marquis Whorsquos Who in the South 2000 - Presentand Southwest and Southwest

Named in Guide to Top Doctors Center for the Study of Services 2002 - Present

Named in Whorsquos Who in the Southwest Marquis Whorsquos Who in the 2003 ndash PresentSouthwest

Named in Whorsquos Who in Medical Academic Keys Whorsquos Who in 2004 - PresentSciences Education Medical Sciences Education

Endowed Chair in Neurosurgery The Methodist Hospital 2005 - PresentNeurological Institute

Certificate of Honor President of the Congress 20105th Int Conference of NeurosurgeryShanghai China

Best Doctors in America U S News and World Report 2010-Present

Best Doctor Honor Role for Castle Connolly Best Doctors 2012-Present5 years or more

Most Compassionate Doctor Award Vitals American Registry 2012-PresentPatientrsquos Choice Award

VISITING PROFESSOR

State University of New York Health Science Center Jan 8 - 9 1999Syracuse New York

Medical College of Georgia Sept 6 - 8 2000Augusta Georgia

Downstate Medical Center Nov 6 - 7 2001Brooklyn NY

Tulane University Medical Center Jan 6 - 7 2005Department of Neurological Surgery

Huashan Institute of Neurological Surgery Nov 17 - 22 2010Huashan HospitalShanghai China

SOCIETIES AND ORGANIZATIONS

Phi Beta Kappa 1974

Sigma Xi 1974

Alpha Omega Alpha 1978

Congress of Neurological Surgeons 1984 - Present

Houston Neurological Society 1984 - Present

Pituitary Society of Houston 1985 - Present

Harris County Medical Society 1985 - Present

Texas Medical Association 1985 - Present

American Medical Association 1985 - Present

Rocky Mountain Neurological Society 1986 - Present

American Heart Association Stroke Council 1986 - Present

American Association for the Advancement of Science 1986 - Present

Joint Section on Spinal Disorders 1986 - PresentCongress of Neurosurgery andThe American Association of Neurological Surgeons

American Association of Neurological Surgeons 1987 - Present

American College of Surgeons 1988 - Present

Society for Neuroscience 1991 - Present

Pituitary Society of America 1993 - Present

Southern Medical Association 1994 - Present

Southern Neurosurgical Society 1996 - Present

Society of University Neurosurgeons 1998 - Present

Society of Neurological Surgeons 2000 - Present

American Academy of Neurological Surgery 2006-Present

Society of Neuro-Oncology 2013-Present

American Society of Clinical Oncology 2013-Present

COMMITTEES

1 Chairman 1984 - 1985Committee on Total Parenteral NutritionHouston Veterans Affairs Medical Center

2 Member 1984 - 1990Executive CommitteeNational Acute Spinal Cord Injury Study(NASCIS II)

3 Member 1984 - 1991Operating Room CommitteeHouston Veterans Affairs Medical Center

4 Member 1984 - 1991Equipment CommitteeHouston Veterans Affairs Medical Center

5 Member 1985 - 1987Human Studies SubcommitteeHouston Veterans Administration Hospital

6 Member 1985 - 1987Medicine Studies Subcommittee Houston Veterans Affairs Medical Center

7 Member 1985 - 1987Research and Development CommitteeHouston Veterans Administration Hospital

8 Member 1985 - 1989Executive CommitteeTreatment of Alzheimers Disease withIntraventricular Bethanechol Chloride

9 Member 1985 - 1991Surgical Intensive Care Unit CommitteeHouston Veterans Affairs Medical Center

10 Member 1986 - 1991Medical District Peer Review Board AdvisorVeterans Affairs Medical Center

11 Member 1986 - 1994Organ Procurement CommitteeThe Methodist Hospital and Baylor College of Medicine

12 Member 1986 - 1994Medical Records CommitteeThe Methodist Hospital

13 Chairman 1987Subcommittee on AIDSGraduate Medical Education CommitteeBaylor College of Medicine

14 Member 1987Open Scientific Session CommitteeCongress of Neurological Surgery

15 Member 1987-1993Curriculum CommitteeBaylor College of Medicine

16 Member 1987-1990Medical School Admissions Committee 1991-1995Baylor College of Medicine

17 Member 1988-1993Texas Council on Alzheimers Diseaseand Related DisordersState of Texas

18 Member 1990-1993Executive CommitteeTexas Council on Alzheimers Disease and Related DisordersState of Texas

19 Member 1991Executive CommitteeNational Acute Spinal Cord Injury Study IIINASCIS III

20 Guest Examiner 1991 2006 2009 2010American Board of Neurological Surgery

21 Chairman 1991-1997Program Advisory Subcommittee of theGraduate Medical Education CommitteeBaylor College of Medicine

22 Medical Advisory Committee 1992-1995The Methodist Health Care NetworkThe Methodist Hospital

23 Member 1993Medical School Admissions Committee Recruitment SubcommitteeBaylor College of Medicine

24 Member 1993Task Force for Curriculum RevisionBaylor College of Medicine

25 Member 1985-2005Committee on Graduate Medical EducationBaylor College of Medicine

26 Member 1988-2000Surgeons Advisory Board Smith Kline Beecham Pharmaceuticals

27 Member 1993-1998Specialized Drug Delivery Devices Subcommittee The Methodist Hospital

28 Member 1995-2005Tissue and Blood Quality Management CommitteeVeterans Affairs Medical Center

29 Chairman 1997-1999Fact Finding SubcommitteeGraduate Medical Education CommitteeBaylor College of Medicine

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

FACULTY POSITIONSPresidential Distinguished Chair Houston Methodist Hospital 2012-PresentDepartment of Neurological Surgery Houston Texas

Director Houston Methodist Hospital 2013-PresentKenneth R Peak Center Brain and Houston TexasPituitary Tumor Treatment Center

Vice Chairman The Methodist Hospital 2007-PresentDepartment of Neurological Surgery Neurological Institute

Professor Weill Cornell Medical College 2007-PresentDepartment of Neurological Surgery New York NY

Research Professor University of Houston 2006-PresentCullen College of Engineering Houston TXDepartment of Electrical andComputer Engineering

Research Professor School of Pharmacy University of Houston 2005-Present

Residency Program Director Houston Methodist Hospital 2005-PresentDepartment of Neurological Surgery Neurological Institute

Adjunct Professor of Neurological Surgery Baylor College of Medicine 2005-PresentHouston Texas

Professor of Neurological Surgery Baylor College of Medicine 1994 - 2005Houston Texas

Professor of Anesthesiology Baylor College of Medicine 1994 - 2005Houston Texas

Associate Professor Baylor College of Medicine 1989 - 1994of Neurological Surgery Houston Texas

Associate Professor Baylor College of Medicine 1993 - 1994of Anesthesiology Houston Texas

Attending Physician Veterans Affairs Medical Center 1991 - 2007Neurological Surgery Houston Texas

Assistant Professor Baylor College of Medicine 1984 - 1989of Neurological Surgery Houston Texas

Assistant Professor Baylor College of Medicine 1985 - 1993Center for Biotechnology Houston Texas

Chief of Neurological Veterans Affairs Medical Center 1984 - 1991Surgery Houston Texas

Attending Physician Houston Methodist Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician Ben Taub Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician Texas Childrens Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician St Lukes Episcopal Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician Memorial Hermann TIRR 1984 - PresentNeurological Surgery

Attending Physician Columbia HCA - Del Oro Hospital 1994 - 1996Neurological Surgery Houston Texas

Attending Physician Texas Orthopedic Hospital 1995 ndash PresentNeurological Surgery Houston Texas

Consulting Physician Johnson Space Center 2012-PresentNeurological Surgery

Special Consultant National Aeronautics and SpaceMonitoring Intracranial Pressure in Space Administration (NASA) 2013-Present

HONORS AND AWARDS

Valedictorian Roxbury High School 1970Succasunna New Jersey

Award for highest Roxbury High School 1970Grade point average Succasunna New Jersey

Phi Beta Kappa Swarthmore College 1974Swarthmore Pennsylvania

Sigma Xi Swarthmore College 1974Swarthmore Pennsylvania

Alpha Omega Alpha Mt Sinai School of Medicine 1978New York New York

James Felt Memorial Mt Sinai School of Medicine 1978Prize Outstanding all- New York New Yorkaround student during the four years of study

Residentrsquos Prize for Federation of Western Societies 1982best scientific paper of Neurological Science

Annual Meeting San Diego California

Academy Award for The American Academy of 1983Original scientific Neurological SurgeryResearch 27th Annual Meeting

Pebble Beach California

Nominee Nominated by Baylor College 1984PEW Foundation Scholars of Medicinein the Biomedical Sciences Houston Texas

Continuing Education The Joint Committee on Education 1986Award in Neurosurgery American Association of Neurological

Surgeons amp Congress of NeurologicalSurgeons

Fellow American Heart Executive Committee of American 1986Association Stroke Council Heart Association Stroke Council

Fellow American College Membership Committee American 1988of Surgeons College of Surgeons

Wakeman Award for Research Wakeman Award Committee 1990in the Neurosciences Duke University

Durham North Carolina

Saul Horowitz Award for the Mt Sinai School of Medicine 1990Outstanding Alumni Achievement New York New York

Named in Whos Who in Medicine Marquis Whorsquos Who in America 1990 - Presentand Healthcare

Selected by Peers to be included in Woodward White Inc 1996 - PresentFirst and Subsequent Editions of the Aiken South CarolinaBest Doctors for America

Elected to Texas Hall of Fame Publishers Plus 1996 - PresentEnglewood New Jersey

Named in Whorsquos Who in Medicine International Whorsquos Who 1997 - Presentand Healthcare of Professionals

Named in Whorsquos Who in the South Marquis Whorsquos Who in the South 2000 - Presentand Southwest and Southwest

Named in Guide to Top Doctors Center for the Study of Services 2002 - Present

Named in Whorsquos Who in the Southwest Marquis Whorsquos Who in the 2003 ndash PresentSouthwest

Named in Whorsquos Who in Medical Academic Keys Whorsquos Who in 2004 - PresentSciences Education Medical Sciences Education

Endowed Chair in Neurosurgery The Methodist Hospital 2005 - PresentNeurological Institute

Certificate of Honor President of the Congress 20105th Int Conference of NeurosurgeryShanghai China

Best Doctors in America U S News and World Report 2010-Present

Best Doctor Honor Role for Castle Connolly Best Doctors 2012-Present5 years or more

Most Compassionate Doctor Award Vitals American Registry 2012-PresentPatientrsquos Choice Award

VISITING PROFESSOR

State University of New York Health Science Center Jan 8 - 9 1999Syracuse New York

Medical College of Georgia Sept 6 - 8 2000Augusta Georgia

Downstate Medical Center Nov 6 - 7 2001Brooklyn NY

Tulane University Medical Center Jan 6 - 7 2005Department of Neurological Surgery

Huashan Institute of Neurological Surgery Nov 17 - 22 2010Huashan HospitalShanghai China

SOCIETIES AND ORGANIZATIONS

Phi Beta Kappa 1974

Sigma Xi 1974

Alpha Omega Alpha 1978

Congress of Neurological Surgeons 1984 - Present

Houston Neurological Society 1984 - Present

Pituitary Society of Houston 1985 - Present

Harris County Medical Society 1985 - Present

Texas Medical Association 1985 - Present

American Medical Association 1985 - Present

Rocky Mountain Neurological Society 1986 - Present

American Heart Association Stroke Council 1986 - Present

American Association for the Advancement of Science 1986 - Present

Joint Section on Spinal Disorders 1986 - PresentCongress of Neurosurgery andThe American Association of Neurological Surgeons

American Association of Neurological Surgeons 1987 - Present

American College of Surgeons 1988 - Present

Society for Neuroscience 1991 - Present

Pituitary Society of America 1993 - Present

Southern Medical Association 1994 - Present

Southern Neurosurgical Society 1996 - Present

Society of University Neurosurgeons 1998 - Present

Society of Neurological Surgeons 2000 - Present

American Academy of Neurological Surgery 2006-Present

Society of Neuro-Oncology 2013-Present

American Society of Clinical Oncology 2013-Present

COMMITTEES

1 Chairman 1984 - 1985Committee on Total Parenteral NutritionHouston Veterans Affairs Medical Center

2 Member 1984 - 1990Executive CommitteeNational Acute Spinal Cord Injury Study(NASCIS II)

3 Member 1984 - 1991Operating Room CommitteeHouston Veterans Affairs Medical Center

4 Member 1984 - 1991Equipment CommitteeHouston Veterans Affairs Medical Center

5 Member 1985 - 1987Human Studies SubcommitteeHouston Veterans Administration Hospital

6 Member 1985 - 1987Medicine Studies Subcommittee Houston Veterans Affairs Medical Center

7 Member 1985 - 1987Research and Development CommitteeHouston Veterans Administration Hospital

8 Member 1985 - 1989Executive CommitteeTreatment of Alzheimers Disease withIntraventricular Bethanechol Chloride

9 Member 1985 - 1991Surgical Intensive Care Unit CommitteeHouston Veterans Affairs Medical Center

10 Member 1986 - 1991Medical District Peer Review Board AdvisorVeterans Affairs Medical Center

11 Member 1986 - 1994Organ Procurement CommitteeThe Methodist Hospital and Baylor College of Medicine

12 Member 1986 - 1994Medical Records CommitteeThe Methodist Hospital

13 Chairman 1987Subcommittee on AIDSGraduate Medical Education CommitteeBaylor College of Medicine

14 Member 1987Open Scientific Session CommitteeCongress of Neurological Surgery

15 Member 1987-1993Curriculum CommitteeBaylor College of Medicine

16 Member 1987-1990Medical School Admissions Committee 1991-1995Baylor College of Medicine

17 Member 1988-1993Texas Council on Alzheimers Diseaseand Related DisordersState of Texas

18 Member 1990-1993Executive CommitteeTexas Council on Alzheimers Disease and Related DisordersState of Texas

19 Member 1991Executive CommitteeNational Acute Spinal Cord Injury Study IIINASCIS III

20 Guest Examiner 1991 2006 2009 2010American Board of Neurological Surgery

21 Chairman 1991-1997Program Advisory Subcommittee of theGraduate Medical Education CommitteeBaylor College of Medicine

22 Medical Advisory Committee 1992-1995The Methodist Health Care NetworkThe Methodist Hospital

23 Member 1993Medical School Admissions Committee Recruitment SubcommitteeBaylor College of Medicine

24 Member 1993Task Force for Curriculum RevisionBaylor College of Medicine

25 Member 1985-2005Committee on Graduate Medical EducationBaylor College of Medicine

26 Member 1988-2000Surgeons Advisory Board Smith Kline Beecham Pharmaceuticals

27 Member 1993-1998Specialized Drug Delivery Devices Subcommittee The Methodist Hospital

28 Member 1995-2005Tissue and Blood Quality Management CommitteeVeterans Affairs Medical Center

29 Chairman 1997-1999Fact Finding SubcommitteeGraduate Medical Education CommitteeBaylor College of Medicine

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Attending Physician Houston Methodist Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician Ben Taub Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician Texas Childrens Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician St Lukes Episcopal Hospital 1984 - PresentNeurological Surgery Houston Texas

Attending Physician Memorial Hermann TIRR 1984 - PresentNeurological Surgery

Attending Physician Columbia HCA - Del Oro Hospital 1994 - 1996Neurological Surgery Houston Texas

Attending Physician Texas Orthopedic Hospital 1995 ndash PresentNeurological Surgery Houston Texas

Consulting Physician Johnson Space Center 2012-PresentNeurological Surgery

Special Consultant National Aeronautics and SpaceMonitoring Intracranial Pressure in Space Administration (NASA) 2013-Present

HONORS AND AWARDS

Valedictorian Roxbury High School 1970Succasunna New Jersey

Award for highest Roxbury High School 1970Grade point average Succasunna New Jersey

Phi Beta Kappa Swarthmore College 1974Swarthmore Pennsylvania

Sigma Xi Swarthmore College 1974Swarthmore Pennsylvania

Alpha Omega Alpha Mt Sinai School of Medicine 1978New York New York

James Felt Memorial Mt Sinai School of Medicine 1978Prize Outstanding all- New York New Yorkaround student during the four years of study

Residentrsquos Prize for Federation of Western Societies 1982best scientific paper of Neurological Science

Annual Meeting San Diego California

Academy Award for The American Academy of 1983Original scientific Neurological SurgeryResearch 27th Annual Meeting

Pebble Beach California

Nominee Nominated by Baylor College 1984PEW Foundation Scholars of Medicinein the Biomedical Sciences Houston Texas

Continuing Education The Joint Committee on Education 1986Award in Neurosurgery American Association of Neurological

Surgeons amp Congress of NeurologicalSurgeons

Fellow American Heart Executive Committee of American 1986Association Stroke Council Heart Association Stroke Council

Fellow American College Membership Committee American 1988of Surgeons College of Surgeons

Wakeman Award for Research Wakeman Award Committee 1990in the Neurosciences Duke University

Durham North Carolina

Saul Horowitz Award for the Mt Sinai School of Medicine 1990Outstanding Alumni Achievement New York New York

Named in Whos Who in Medicine Marquis Whorsquos Who in America 1990 - Presentand Healthcare

Selected by Peers to be included in Woodward White Inc 1996 - PresentFirst and Subsequent Editions of the Aiken South CarolinaBest Doctors for America

Elected to Texas Hall of Fame Publishers Plus 1996 - PresentEnglewood New Jersey

Named in Whorsquos Who in Medicine International Whorsquos Who 1997 - Presentand Healthcare of Professionals

Named in Whorsquos Who in the South Marquis Whorsquos Who in the South 2000 - Presentand Southwest and Southwest

Named in Guide to Top Doctors Center for the Study of Services 2002 - Present

Named in Whorsquos Who in the Southwest Marquis Whorsquos Who in the 2003 ndash PresentSouthwest

Named in Whorsquos Who in Medical Academic Keys Whorsquos Who in 2004 - PresentSciences Education Medical Sciences Education

Endowed Chair in Neurosurgery The Methodist Hospital 2005 - PresentNeurological Institute

Certificate of Honor President of the Congress 20105th Int Conference of NeurosurgeryShanghai China

Best Doctors in America U S News and World Report 2010-Present

Best Doctor Honor Role for Castle Connolly Best Doctors 2012-Present5 years or more

Most Compassionate Doctor Award Vitals American Registry 2012-PresentPatientrsquos Choice Award

VISITING PROFESSOR

State University of New York Health Science Center Jan 8 - 9 1999Syracuse New York

Medical College of Georgia Sept 6 - 8 2000Augusta Georgia

Downstate Medical Center Nov 6 - 7 2001Brooklyn NY

Tulane University Medical Center Jan 6 - 7 2005Department of Neurological Surgery

Huashan Institute of Neurological Surgery Nov 17 - 22 2010Huashan HospitalShanghai China

SOCIETIES AND ORGANIZATIONS

Phi Beta Kappa 1974

Sigma Xi 1974

Alpha Omega Alpha 1978

Congress of Neurological Surgeons 1984 - Present

Houston Neurological Society 1984 - Present

Pituitary Society of Houston 1985 - Present

Harris County Medical Society 1985 - Present

Texas Medical Association 1985 - Present

American Medical Association 1985 - Present

Rocky Mountain Neurological Society 1986 - Present

American Heart Association Stroke Council 1986 - Present

American Association for the Advancement of Science 1986 - Present

Joint Section on Spinal Disorders 1986 - PresentCongress of Neurosurgery andThe American Association of Neurological Surgeons

American Association of Neurological Surgeons 1987 - Present

American College of Surgeons 1988 - Present

Society for Neuroscience 1991 - Present

Pituitary Society of America 1993 - Present

Southern Medical Association 1994 - Present

Southern Neurosurgical Society 1996 - Present

Society of University Neurosurgeons 1998 - Present

Society of Neurological Surgeons 2000 - Present

American Academy of Neurological Surgery 2006-Present

Society of Neuro-Oncology 2013-Present

American Society of Clinical Oncology 2013-Present

COMMITTEES

1 Chairman 1984 - 1985Committee on Total Parenteral NutritionHouston Veterans Affairs Medical Center

2 Member 1984 - 1990Executive CommitteeNational Acute Spinal Cord Injury Study(NASCIS II)

3 Member 1984 - 1991Operating Room CommitteeHouston Veterans Affairs Medical Center

4 Member 1984 - 1991Equipment CommitteeHouston Veterans Affairs Medical Center

5 Member 1985 - 1987Human Studies SubcommitteeHouston Veterans Administration Hospital

6 Member 1985 - 1987Medicine Studies Subcommittee Houston Veterans Affairs Medical Center

7 Member 1985 - 1987Research and Development CommitteeHouston Veterans Administration Hospital

8 Member 1985 - 1989Executive CommitteeTreatment of Alzheimers Disease withIntraventricular Bethanechol Chloride

9 Member 1985 - 1991Surgical Intensive Care Unit CommitteeHouston Veterans Affairs Medical Center

10 Member 1986 - 1991Medical District Peer Review Board AdvisorVeterans Affairs Medical Center

11 Member 1986 - 1994Organ Procurement CommitteeThe Methodist Hospital and Baylor College of Medicine

12 Member 1986 - 1994Medical Records CommitteeThe Methodist Hospital

13 Chairman 1987Subcommittee on AIDSGraduate Medical Education CommitteeBaylor College of Medicine

14 Member 1987Open Scientific Session CommitteeCongress of Neurological Surgery

15 Member 1987-1993Curriculum CommitteeBaylor College of Medicine

16 Member 1987-1990Medical School Admissions Committee 1991-1995Baylor College of Medicine

17 Member 1988-1993Texas Council on Alzheimers Diseaseand Related DisordersState of Texas

18 Member 1990-1993Executive CommitteeTexas Council on Alzheimers Disease and Related DisordersState of Texas

19 Member 1991Executive CommitteeNational Acute Spinal Cord Injury Study IIINASCIS III

20 Guest Examiner 1991 2006 2009 2010American Board of Neurological Surgery

21 Chairman 1991-1997Program Advisory Subcommittee of theGraduate Medical Education CommitteeBaylor College of Medicine

22 Medical Advisory Committee 1992-1995The Methodist Health Care NetworkThe Methodist Hospital

23 Member 1993Medical School Admissions Committee Recruitment SubcommitteeBaylor College of Medicine

24 Member 1993Task Force for Curriculum RevisionBaylor College of Medicine

25 Member 1985-2005Committee on Graduate Medical EducationBaylor College of Medicine

26 Member 1988-2000Surgeons Advisory Board Smith Kline Beecham Pharmaceuticals

27 Member 1993-1998Specialized Drug Delivery Devices Subcommittee The Methodist Hospital

28 Member 1995-2005Tissue and Blood Quality Management CommitteeVeterans Affairs Medical Center

29 Chairman 1997-1999Fact Finding SubcommitteeGraduate Medical Education CommitteeBaylor College of Medicine

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

HONORS AND AWARDS

Valedictorian Roxbury High School 1970Succasunna New Jersey

Award for highest Roxbury High School 1970Grade point average Succasunna New Jersey

Phi Beta Kappa Swarthmore College 1974Swarthmore Pennsylvania

Sigma Xi Swarthmore College 1974Swarthmore Pennsylvania

Alpha Omega Alpha Mt Sinai School of Medicine 1978New York New York

James Felt Memorial Mt Sinai School of Medicine 1978Prize Outstanding all- New York New Yorkaround student during the four years of study

Residentrsquos Prize for Federation of Western Societies 1982best scientific paper of Neurological Science

Annual Meeting San Diego California

Academy Award for The American Academy of 1983Original scientific Neurological SurgeryResearch 27th Annual Meeting

Pebble Beach California

Nominee Nominated by Baylor College 1984PEW Foundation Scholars of Medicinein the Biomedical Sciences Houston Texas

Continuing Education The Joint Committee on Education 1986Award in Neurosurgery American Association of Neurological

Surgeons amp Congress of NeurologicalSurgeons

Fellow American Heart Executive Committee of American 1986Association Stroke Council Heart Association Stroke Council

Fellow American College Membership Committee American 1988of Surgeons College of Surgeons

Wakeman Award for Research Wakeman Award Committee 1990in the Neurosciences Duke University

Durham North Carolina

Saul Horowitz Award for the Mt Sinai School of Medicine 1990Outstanding Alumni Achievement New York New York

Named in Whos Who in Medicine Marquis Whorsquos Who in America 1990 - Presentand Healthcare

Selected by Peers to be included in Woodward White Inc 1996 - PresentFirst and Subsequent Editions of the Aiken South CarolinaBest Doctors for America

Elected to Texas Hall of Fame Publishers Plus 1996 - PresentEnglewood New Jersey

Named in Whorsquos Who in Medicine International Whorsquos Who 1997 - Presentand Healthcare of Professionals

Named in Whorsquos Who in the South Marquis Whorsquos Who in the South 2000 - Presentand Southwest and Southwest

Named in Guide to Top Doctors Center for the Study of Services 2002 - Present

Named in Whorsquos Who in the Southwest Marquis Whorsquos Who in the 2003 ndash PresentSouthwest

Named in Whorsquos Who in Medical Academic Keys Whorsquos Who in 2004 - PresentSciences Education Medical Sciences Education

Endowed Chair in Neurosurgery The Methodist Hospital 2005 - PresentNeurological Institute

Certificate of Honor President of the Congress 20105th Int Conference of NeurosurgeryShanghai China

Best Doctors in America U S News and World Report 2010-Present

Best Doctor Honor Role for Castle Connolly Best Doctors 2012-Present5 years or more

Most Compassionate Doctor Award Vitals American Registry 2012-PresentPatientrsquos Choice Award

VISITING PROFESSOR

State University of New York Health Science Center Jan 8 - 9 1999Syracuse New York

Medical College of Georgia Sept 6 - 8 2000Augusta Georgia

Downstate Medical Center Nov 6 - 7 2001Brooklyn NY

Tulane University Medical Center Jan 6 - 7 2005Department of Neurological Surgery

Huashan Institute of Neurological Surgery Nov 17 - 22 2010Huashan HospitalShanghai China

SOCIETIES AND ORGANIZATIONS

Phi Beta Kappa 1974

Sigma Xi 1974

Alpha Omega Alpha 1978

Congress of Neurological Surgeons 1984 - Present

Houston Neurological Society 1984 - Present

Pituitary Society of Houston 1985 - Present

Harris County Medical Society 1985 - Present

Texas Medical Association 1985 - Present

American Medical Association 1985 - Present

Rocky Mountain Neurological Society 1986 - Present

American Heart Association Stroke Council 1986 - Present

American Association for the Advancement of Science 1986 - Present

Joint Section on Spinal Disorders 1986 - PresentCongress of Neurosurgery andThe American Association of Neurological Surgeons

American Association of Neurological Surgeons 1987 - Present

American College of Surgeons 1988 - Present

Society for Neuroscience 1991 - Present

Pituitary Society of America 1993 - Present

Southern Medical Association 1994 - Present

Southern Neurosurgical Society 1996 - Present

Society of University Neurosurgeons 1998 - Present

Society of Neurological Surgeons 2000 - Present

American Academy of Neurological Surgery 2006-Present

Society of Neuro-Oncology 2013-Present

American Society of Clinical Oncology 2013-Present

COMMITTEES

1 Chairman 1984 - 1985Committee on Total Parenteral NutritionHouston Veterans Affairs Medical Center

2 Member 1984 - 1990Executive CommitteeNational Acute Spinal Cord Injury Study(NASCIS II)

3 Member 1984 - 1991Operating Room CommitteeHouston Veterans Affairs Medical Center

4 Member 1984 - 1991Equipment CommitteeHouston Veterans Affairs Medical Center

5 Member 1985 - 1987Human Studies SubcommitteeHouston Veterans Administration Hospital

6 Member 1985 - 1987Medicine Studies Subcommittee Houston Veterans Affairs Medical Center

7 Member 1985 - 1987Research and Development CommitteeHouston Veterans Administration Hospital

8 Member 1985 - 1989Executive CommitteeTreatment of Alzheimers Disease withIntraventricular Bethanechol Chloride

9 Member 1985 - 1991Surgical Intensive Care Unit CommitteeHouston Veterans Affairs Medical Center

10 Member 1986 - 1991Medical District Peer Review Board AdvisorVeterans Affairs Medical Center

11 Member 1986 - 1994Organ Procurement CommitteeThe Methodist Hospital and Baylor College of Medicine

12 Member 1986 - 1994Medical Records CommitteeThe Methodist Hospital

13 Chairman 1987Subcommittee on AIDSGraduate Medical Education CommitteeBaylor College of Medicine

14 Member 1987Open Scientific Session CommitteeCongress of Neurological Surgery

15 Member 1987-1993Curriculum CommitteeBaylor College of Medicine

16 Member 1987-1990Medical School Admissions Committee 1991-1995Baylor College of Medicine

17 Member 1988-1993Texas Council on Alzheimers Diseaseand Related DisordersState of Texas

18 Member 1990-1993Executive CommitteeTexas Council on Alzheimers Disease and Related DisordersState of Texas

19 Member 1991Executive CommitteeNational Acute Spinal Cord Injury Study IIINASCIS III

20 Guest Examiner 1991 2006 2009 2010American Board of Neurological Surgery

21 Chairman 1991-1997Program Advisory Subcommittee of theGraduate Medical Education CommitteeBaylor College of Medicine

22 Medical Advisory Committee 1992-1995The Methodist Health Care NetworkThe Methodist Hospital

23 Member 1993Medical School Admissions Committee Recruitment SubcommitteeBaylor College of Medicine

24 Member 1993Task Force for Curriculum RevisionBaylor College of Medicine

25 Member 1985-2005Committee on Graduate Medical EducationBaylor College of Medicine

26 Member 1988-2000Surgeons Advisory Board Smith Kline Beecham Pharmaceuticals

27 Member 1993-1998Specialized Drug Delivery Devices Subcommittee The Methodist Hospital

28 Member 1995-2005Tissue and Blood Quality Management CommitteeVeterans Affairs Medical Center

29 Chairman 1997-1999Fact Finding SubcommitteeGraduate Medical Education CommitteeBaylor College of Medicine

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Saul Horowitz Award for the Mt Sinai School of Medicine 1990Outstanding Alumni Achievement New York New York

Named in Whos Who in Medicine Marquis Whorsquos Who in America 1990 - Presentand Healthcare

Selected by Peers to be included in Woodward White Inc 1996 - PresentFirst and Subsequent Editions of the Aiken South CarolinaBest Doctors for America

Elected to Texas Hall of Fame Publishers Plus 1996 - PresentEnglewood New Jersey

Named in Whorsquos Who in Medicine International Whorsquos Who 1997 - Presentand Healthcare of Professionals

Named in Whorsquos Who in the South Marquis Whorsquos Who in the South 2000 - Presentand Southwest and Southwest

Named in Guide to Top Doctors Center for the Study of Services 2002 - Present

Named in Whorsquos Who in the Southwest Marquis Whorsquos Who in the 2003 ndash PresentSouthwest

Named in Whorsquos Who in Medical Academic Keys Whorsquos Who in 2004 - PresentSciences Education Medical Sciences Education

Endowed Chair in Neurosurgery The Methodist Hospital 2005 - PresentNeurological Institute

Certificate of Honor President of the Congress 20105th Int Conference of NeurosurgeryShanghai China

Best Doctors in America U S News and World Report 2010-Present

Best Doctor Honor Role for Castle Connolly Best Doctors 2012-Present5 years or more

Most Compassionate Doctor Award Vitals American Registry 2012-PresentPatientrsquos Choice Award

VISITING PROFESSOR

State University of New York Health Science Center Jan 8 - 9 1999Syracuse New York

Medical College of Georgia Sept 6 - 8 2000Augusta Georgia

Downstate Medical Center Nov 6 - 7 2001Brooklyn NY

Tulane University Medical Center Jan 6 - 7 2005Department of Neurological Surgery

Huashan Institute of Neurological Surgery Nov 17 - 22 2010Huashan HospitalShanghai China

SOCIETIES AND ORGANIZATIONS

Phi Beta Kappa 1974

Sigma Xi 1974

Alpha Omega Alpha 1978

Congress of Neurological Surgeons 1984 - Present

Houston Neurological Society 1984 - Present

Pituitary Society of Houston 1985 - Present

Harris County Medical Society 1985 - Present

Texas Medical Association 1985 - Present

American Medical Association 1985 - Present

Rocky Mountain Neurological Society 1986 - Present

American Heart Association Stroke Council 1986 - Present

American Association for the Advancement of Science 1986 - Present

Joint Section on Spinal Disorders 1986 - PresentCongress of Neurosurgery andThe American Association of Neurological Surgeons

American Association of Neurological Surgeons 1987 - Present

American College of Surgeons 1988 - Present

Society for Neuroscience 1991 - Present

Pituitary Society of America 1993 - Present

Southern Medical Association 1994 - Present

Southern Neurosurgical Society 1996 - Present

Society of University Neurosurgeons 1998 - Present

Society of Neurological Surgeons 2000 - Present

American Academy of Neurological Surgery 2006-Present

Society of Neuro-Oncology 2013-Present

American Society of Clinical Oncology 2013-Present

COMMITTEES

1 Chairman 1984 - 1985Committee on Total Parenteral NutritionHouston Veterans Affairs Medical Center

2 Member 1984 - 1990Executive CommitteeNational Acute Spinal Cord Injury Study(NASCIS II)

3 Member 1984 - 1991Operating Room CommitteeHouston Veterans Affairs Medical Center

4 Member 1984 - 1991Equipment CommitteeHouston Veterans Affairs Medical Center

5 Member 1985 - 1987Human Studies SubcommitteeHouston Veterans Administration Hospital

6 Member 1985 - 1987Medicine Studies Subcommittee Houston Veterans Affairs Medical Center

7 Member 1985 - 1987Research and Development CommitteeHouston Veterans Administration Hospital

8 Member 1985 - 1989Executive CommitteeTreatment of Alzheimers Disease withIntraventricular Bethanechol Chloride

9 Member 1985 - 1991Surgical Intensive Care Unit CommitteeHouston Veterans Affairs Medical Center

10 Member 1986 - 1991Medical District Peer Review Board AdvisorVeterans Affairs Medical Center

11 Member 1986 - 1994Organ Procurement CommitteeThe Methodist Hospital and Baylor College of Medicine

12 Member 1986 - 1994Medical Records CommitteeThe Methodist Hospital

13 Chairman 1987Subcommittee on AIDSGraduate Medical Education CommitteeBaylor College of Medicine

14 Member 1987Open Scientific Session CommitteeCongress of Neurological Surgery

15 Member 1987-1993Curriculum CommitteeBaylor College of Medicine

16 Member 1987-1990Medical School Admissions Committee 1991-1995Baylor College of Medicine

17 Member 1988-1993Texas Council on Alzheimers Diseaseand Related DisordersState of Texas

18 Member 1990-1993Executive CommitteeTexas Council on Alzheimers Disease and Related DisordersState of Texas

19 Member 1991Executive CommitteeNational Acute Spinal Cord Injury Study IIINASCIS III

20 Guest Examiner 1991 2006 2009 2010American Board of Neurological Surgery

21 Chairman 1991-1997Program Advisory Subcommittee of theGraduate Medical Education CommitteeBaylor College of Medicine

22 Medical Advisory Committee 1992-1995The Methodist Health Care NetworkThe Methodist Hospital

23 Member 1993Medical School Admissions Committee Recruitment SubcommitteeBaylor College of Medicine

24 Member 1993Task Force for Curriculum RevisionBaylor College of Medicine

25 Member 1985-2005Committee on Graduate Medical EducationBaylor College of Medicine

26 Member 1988-2000Surgeons Advisory Board Smith Kline Beecham Pharmaceuticals

27 Member 1993-1998Specialized Drug Delivery Devices Subcommittee The Methodist Hospital

28 Member 1995-2005Tissue and Blood Quality Management CommitteeVeterans Affairs Medical Center

29 Chairman 1997-1999Fact Finding SubcommitteeGraduate Medical Education CommitteeBaylor College of Medicine

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

VISITING PROFESSOR

State University of New York Health Science Center Jan 8 - 9 1999Syracuse New York

Medical College of Georgia Sept 6 - 8 2000Augusta Georgia

Downstate Medical Center Nov 6 - 7 2001Brooklyn NY

Tulane University Medical Center Jan 6 - 7 2005Department of Neurological Surgery

Huashan Institute of Neurological Surgery Nov 17 - 22 2010Huashan HospitalShanghai China

SOCIETIES AND ORGANIZATIONS

Phi Beta Kappa 1974

Sigma Xi 1974

Alpha Omega Alpha 1978

Congress of Neurological Surgeons 1984 - Present

Houston Neurological Society 1984 - Present

Pituitary Society of Houston 1985 - Present

Harris County Medical Society 1985 - Present

Texas Medical Association 1985 - Present

American Medical Association 1985 - Present

Rocky Mountain Neurological Society 1986 - Present

American Heart Association Stroke Council 1986 - Present

American Association for the Advancement of Science 1986 - Present

Joint Section on Spinal Disorders 1986 - PresentCongress of Neurosurgery andThe American Association of Neurological Surgeons

American Association of Neurological Surgeons 1987 - Present

American College of Surgeons 1988 - Present

Society for Neuroscience 1991 - Present

Pituitary Society of America 1993 - Present

Southern Medical Association 1994 - Present

Southern Neurosurgical Society 1996 - Present

Society of University Neurosurgeons 1998 - Present

Society of Neurological Surgeons 2000 - Present

American Academy of Neurological Surgery 2006-Present

Society of Neuro-Oncology 2013-Present

American Society of Clinical Oncology 2013-Present

COMMITTEES

1 Chairman 1984 - 1985Committee on Total Parenteral NutritionHouston Veterans Affairs Medical Center

2 Member 1984 - 1990Executive CommitteeNational Acute Spinal Cord Injury Study(NASCIS II)

3 Member 1984 - 1991Operating Room CommitteeHouston Veterans Affairs Medical Center

4 Member 1984 - 1991Equipment CommitteeHouston Veterans Affairs Medical Center

5 Member 1985 - 1987Human Studies SubcommitteeHouston Veterans Administration Hospital

6 Member 1985 - 1987Medicine Studies Subcommittee Houston Veterans Affairs Medical Center

7 Member 1985 - 1987Research and Development CommitteeHouston Veterans Administration Hospital

8 Member 1985 - 1989Executive CommitteeTreatment of Alzheimers Disease withIntraventricular Bethanechol Chloride

9 Member 1985 - 1991Surgical Intensive Care Unit CommitteeHouston Veterans Affairs Medical Center

10 Member 1986 - 1991Medical District Peer Review Board AdvisorVeterans Affairs Medical Center

11 Member 1986 - 1994Organ Procurement CommitteeThe Methodist Hospital and Baylor College of Medicine

12 Member 1986 - 1994Medical Records CommitteeThe Methodist Hospital

13 Chairman 1987Subcommittee on AIDSGraduate Medical Education CommitteeBaylor College of Medicine

14 Member 1987Open Scientific Session CommitteeCongress of Neurological Surgery

15 Member 1987-1993Curriculum CommitteeBaylor College of Medicine

16 Member 1987-1990Medical School Admissions Committee 1991-1995Baylor College of Medicine

17 Member 1988-1993Texas Council on Alzheimers Diseaseand Related DisordersState of Texas

18 Member 1990-1993Executive CommitteeTexas Council on Alzheimers Disease and Related DisordersState of Texas

19 Member 1991Executive CommitteeNational Acute Spinal Cord Injury Study IIINASCIS III

20 Guest Examiner 1991 2006 2009 2010American Board of Neurological Surgery

21 Chairman 1991-1997Program Advisory Subcommittee of theGraduate Medical Education CommitteeBaylor College of Medicine

22 Medical Advisory Committee 1992-1995The Methodist Health Care NetworkThe Methodist Hospital

23 Member 1993Medical School Admissions Committee Recruitment SubcommitteeBaylor College of Medicine

24 Member 1993Task Force for Curriculum RevisionBaylor College of Medicine

25 Member 1985-2005Committee on Graduate Medical EducationBaylor College of Medicine

26 Member 1988-2000Surgeons Advisory Board Smith Kline Beecham Pharmaceuticals

27 Member 1993-1998Specialized Drug Delivery Devices Subcommittee The Methodist Hospital

28 Member 1995-2005Tissue and Blood Quality Management CommitteeVeterans Affairs Medical Center

29 Chairman 1997-1999Fact Finding SubcommitteeGraduate Medical Education CommitteeBaylor College of Medicine

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Pituitary Society of America 1993 - Present

Southern Medical Association 1994 - Present

Southern Neurosurgical Society 1996 - Present

Society of University Neurosurgeons 1998 - Present

Society of Neurological Surgeons 2000 - Present

American Academy of Neurological Surgery 2006-Present

Society of Neuro-Oncology 2013-Present

American Society of Clinical Oncology 2013-Present

COMMITTEES

1 Chairman 1984 - 1985Committee on Total Parenteral NutritionHouston Veterans Affairs Medical Center

2 Member 1984 - 1990Executive CommitteeNational Acute Spinal Cord Injury Study(NASCIS II)

3 Member 1984 - 1991Operating Room CommitteeHouston Veterans Affairs Medical Center

4 Member 1984 - 1991Equipment CommitteeHouston Veterans Affairs Medical Center

5 Member 1985 - 1987Human Studies SubcommitteeHouston Veterans Administration Hospital

6 Member 1985 - 1987Medicine Studies Subcommittee Houston Veterans Affairs Medical Center

7 Member 1985 - 1987Research and Development CommitteeHouston Veterans Administration Hospital

8 Member 1985 - 1989Executive CommitteeTreatment of Alzheimers Disease withIntraventricular Bethanechol Chloride

9 Member 1985 - 1991Surgical Intensive Care Unit CommitteeHouston Veterans Affairs Medical Center

10 Member 1986 - 1991Medical District Peer Review Board AdvisorVeterans Affairs Medical Center

11 Member 1986 - 1994Organ Procurement CommitteeThe Methodist Hospital and Baylor College of Medicine

12 Member 1986 - 1994Medical Records CommitteeThe Methodist Hospital

13 Chairman 1987Subcommittee on AIDSGraduate Medical Education CommitteeBaylor College of Medicine

14 Member 1987Open Scientific Session CommitteeCongress of Neurological Surgery

15 Member 1987-1993Curriculum CommitteeBaylor College of Medicine

16 Member 1987-1990Medical School Admissions Committee 1991-1995Baylor College of Medicine

17 Member 1988-1993Texas Council on Alzheimers Diseaseand Related DisordersState of Texas

18 Member 1990-1993Executive CommitteeTexas Council on Alzheimers Disease and Related DisordersState of Texas

19 Member 1991Executive CommitteeNational Acute Spinal Cord Injury Study IIINASCIS III

20 Guest Examiner 1991 2006 2009 2010American Board of Neurological Surgery

21 Chairman 1991-1997Program Advisory Subcommittee of theGraduate Medical Education CommitteeBaylor College of Medicine

22 Medical Advisory Committee 1992-1995The Methodist Health Care NetworkThe Methodist Hospital

23 Member 1993Medical School Admissions Committee Recruitment SubcommitteeBaylor College of Medicine

24 Member 1993Task Force for Curriculum RevisionBaylor College of Medicine

25 Member 1985-2005Committee on Graduate Medical EducationBaylor College of Medicine

26 Member 1988-2000Surgeons Advisory Board Smith Kline Beecham Pharmaceuticals

27 Member 1993-1998Specialized Drug Delivery Devices Subcommittee The Methodist Hospital

28 Member 1995-2005Tissue and Blood Quality Management CommitteeVeterans Affairs Medical Center

29 Chairman 1997-1999Fact Finding SubcommitteeGraduate Medical Education CommitteeBaylor College of Medicine

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

8 Member 1985 - 1989Executive CommitteeTreatment of Alzheimers Disease withIntraventricular Bethanechol Chloride

9 Member 1985 - 1991Surgical Intensive Care Unit CommitteeHouston Veterans Affairs Medical Center

10 Member 1986 - 1991Medical District Peer Review Board AdvisorVeterans Affairs Medical Center

11 Member 1986 - 1994Organ Procurement CommitteeThe Methodist Hospital and Baylor College of Medicine

12 Member 1986 - 1994Medical Records CommitteeThe Methodist Hospital

13 Chairman 1987Subcommittee on AIDSGraduate Medical Education CommitteeBaylor College of Medicine

14 Member 1987Open Scientific Session CommitteeCongress of Neurological Surgery

15 Member 1987-1993Curriculum CommitteeBaylor College of Medicine

16 Member 1987-1990Medical School Admissions Committee 1991-1995Baylor College of Medicine

17 Member 1988-1993Texas Council on Alzheimers Diseaseand Related DisordersState of Texas

18 Member 1990-1993Executive CommitteeTexas Council on Alzheimers Disease and Related DisordersState of Texas

19 Member 1991Executive CommitteeNational Acute Spinal Cord Injury Study IIINASCIS III

20 Guest Examiner 1991 2006 2009 2010American Board of Neurological Surgery

21 Chairman 1991-1997Program Advisory Subcommittee of theGraduate Medical Education CommitteeBaylor College of Medicine

22 Medical Advisory Committee 1992-1995The Methodist Health Care NetworkThe Methodist Hospital

23 Member 1993Medical School Admissions Committee Recruitment SubcommitteeBaylor College of Medicine

24 Member 1993Task Force for Curriculum RevisionBaylor College of Medicine

25 Member 1985-2005Committee on Graduate Medical EducationBaylor College of Medicine

26 Member 1988-2000Surgeons Advisory Board Smith Kline Beecham Pharmaceuticals

27 Member 1993-1998Specialized Drug Delivery Devices Subcommittee The Methodist Hospital

28 Member 1995-2005Tissue and Blood Quality Management CommitteeVeterans Affairs Medical Center

29 Chairman 1997-1999Fact Finding SubcommitteeGraduate Medical Education CommitteeBaylor College of Medicine

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

19 Member 1991Executive CommitteeNational Acute Spinal Cord Injury Study IIINASCIS III

20 Guest Examiner 1991 2006 2009 2010American Board of Neurological Surgery

21 Chairman 1991-1997Program Advisory Subcommittee of theGraduate Medical Education CommitteeBaylor College of Medicine

22 Medical Advisory Committee 1992-1995The Methodist Health Care NetworkThe Methodist Hospital

23 Member 1993Medical School Admissions Committee Recruitment SubcommitteeBaylor College of Medicine

24 Member 1993Task Force for Curriculum RevisionBaylor College of Medicine

25 Member 1985-2005Committee on Graduate Medical EducationBaylor College of Medicine

26 Member 1988-2000Surgeons Advisory Board Smith Kline Beecham Pharmaceuticals

27 Member 1993-1998Specialized Drug Delivery Devices Subcommittee The Methodist Hospital

28 Member 1995-2005Tissue and Blood Quality Management CommitteeVeterans Affairs Medical Center

29 Chairman 1997-1999Fact Finding SubcommitteeGraduate Medical Education CommitteeBaylor College of Medicine

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

30 Member 1997-1999Medical Records CommitteeThe Methodist Hospital

31 Member 1997-2005Satellite Healthcare NetworkFaculty Advisory CommitteeBaylor College of Medicine

32 Member 1998-2000BaylorMedCareregProfessional Fees CommitteeBaylor College of Medicine

33 Chairman 1999-2005Administrative Subcommittee GMECBaylor College of Medicine

34 Vice Chairman 1999-2004Graduate Medical Education CommitteeBaylor College of Medicine

35 Member 1999-2001Emergency Room and Intensive Care Units CommitteeThe Methodist Hospital

36 Member 1999-2001Clinical Pathway Committee in Acute StrokeThe Methodist Hospital

37 Chairman 2002-2005Neuro-Oncology SectionDepartment of NeurosurgeryBaylor College of Medicine

38 Member 2002-2006Physician Palliative Care Advisory GroupThe Methodist Hospital

39 Member 2002-2007American College of SurgeonsSurgical Research Committee

40 Member 2002-PresentCancer BoardThe Methodist Hospital

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

41 Member 2004-2007Research CommitteeSociety of Neurological Surgeons

42 Member 2005-PresentGraduate Medical Education CommitteeThe Methodist Hospital

43 Member 2006-PresentExecutive CommitteeGraduate Medical Education Committee

44 Member 2007-PresentAdministrative Subcommittee on Resident PerformanceGraduate Medical Education CommitteeThe Methodist Hospital

45 Member 2011-PresentCode of Conduct PanelThe Methodist Hospital

46 Member 2013-PresentHouston Methodist Cancer Governance Council

JOURNAL REFEREEJournal of NeurosurgeryLife SciencesPharmaceutical ResearchJournal of NeurofibromatosisAHFS Drug InformationBrain ResearchPhysiology amp BehaviorNeurosurgeryAnnals of NeurologyWorld Neurosurgery

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

SCIENTIFIC REVIEW COMMITTEES

Chairperson Study Section December 6 2004National Institutes of HealthNational Institute of Environmental Health Sciences Special Emphasis Panel ZES1 LKB-A (K1)

Primary Reviewer Study Section February 2007National Institutes of HealthNational Institute of Environmental Health Sciences

Member 2001-2007Scientific Review BoardCure Autism Now Foundation]

Co-Chair 1999-2007Scientific Review CouncilCure Autism Now Foundation

Member 2008-PresentScientific Advisory CouncilAutism Speaks

MemberVisual ImpairmentIntracranial Pressure Research and Clinical Advisory Panel 2011-Present National Aeronautics and Space Administration (NASA)

MemberScientific Review Panel for Final Grant Approval 2013-PresentAutism Speaks

Member March 2013-PresentNASANSBRI Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support Services

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

GRANTSPrior Support

Co-Investigator $2000Reversal of Experimental Ischemic Neurological Deficit in Gerbils by the Opiate Antagonist Naloxone Academic SenateCommittee on Research San Francisco Division 1982

Co-Investigator $163350Therapeutic Action of Opiate Antagonists in Acute StrokeNINCDS Grant 1 RO1 - NS20620-011984

Principal Investigator $9000Treatment of Acute Stroke with Opiate AntagonistsBiomedical Research Support Grant Baylor College of Medicine1984

Principal Investigator $51000Treatment of Acute Stroke with Opiate AntagonistsResearch Advisory Groups Veterans Administration 1985Principal Investigator $60000Treatment of Acute Stroke with Opiate AntagonistsSmith Kline and French Fellowship of the American College of Surgeons1985-1987

Principal Investigator $180000Opiate Antagonists in Cerebral IschemiaVeterans Administration Merit Review Grant1985-1989

Co-Investigator $364450Nuclear Magnetic Resonance Evaluation of StrokeNIH 32 RO1 NS19056-041986

Principal Investigator $24000Kappa Agonists in Cerebral IschemiaDuPont Critical Care1989-1990

Principal Investigator $7500A New Kappa Agonist for Cerebral IschemiaDuPont Critical Care1989

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Principal Investigator $241500Kappa Opioids in Cerebral IschemiaVeterans Administration Merit Review Grant1990-1993

Principal Investigator $40000Anti-Oxidants in Cerebral IschemiaThe Pauline-Sterne Wolff Memorial Foundation1992-1994

Principal Investigator $60000Efficacy Safety Study of Tirilazad Mesylate (U-74006F) in Patientswith Subarachnoid HemorrhageThe Upjohn Company1992-1997

Principal Investigator $81740Mechanism of Action of Kappa OpioidsThe American Heart Association1993-1996

Principal Investigator $199400Mechanism and Site of Action of Kappa Opioids in Cerebral IschemiaVeterans Affairs Merit Review Grant 1993-1997Principal Investigator $30000Treatment of Stroke and Subarachnoid HemorrhagePauline Sterne Wolff Memorial Foundation1995-1996

Principal Investigator $75000Treatment of Brain Edema with Kappa OpioidsThe Taub Foundation1993-1998

Principal Investigator $1000Treatment of Stroke and Subarachnoid Hemorrhage with Tirilizad MesylateGeorge A Robinson IV Foundation1994-1998

Principal Investigator $1000New Agents for Treatment of StrokeGeorge A Robinson IV Foundation1995-1998

Principal Investigator $30000Kappa Opioid Neuroprotection in StrokeBaylor College of Medicine Program for Interim Support1997-1998

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Principal Investigator $7000Molecular Biology of StrokeGeorge A Robinson IV Foundation1997-2000

Principal Investigator $30000Molecular Biology of IschemiaPauline Sterne Wolff Memorial Foundation1997-2000

Principal Investigator $130870A New and Specific Assay for Detection of Apoptotic Cell DeathTexas Higher Education Coordinating Board Advanced Technology Program1998-1999

Principal Investigator $309190In Situ Ligation for Detection of Specific DNA DamageNational Cancer Institute NIH1 R01 CA78912-011998-2002

Principal Investigator $140000Imaging of Cellular Processes in vivo Using FullerenesTexas Higher Education Coordinating Board Advanced Technology Program2002-2003

Co-Principal Investigator and President and CEO $399100Molecular Probes to Image DNA Damage in Brain CellsNational Institute of Mental Health NIH1999-2004

Principal Investigator $398300Molecular Probes to Image DNA Damage in Live and Fixed Brain CellsVeterans Affairs Merit Review Grant2001-2004

Laboratory Director $25200Fluorescence Resonance Energy Transfer BasedDetection of Caspase 3 in Tissue SectionsRoche Diagnostics1999-2005

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Principal Investigator $200000Nanotechnology for in Vivo Imaging of ApoptosisUsing Protein-Directed Fullerene ComplexesTexas Higher Education Coordinating Board Advanced Technology Program2004-2005

Principal Investigator $54545Differential Effects of Thimerosal on Cell Division and Apoptosis inNormal versus Autism Spectrum Disorder Cell Lines Autism Speaks2008-2009

Principal Investigator $200000Targeted Therapy of Glioblastoma Using Immunogens Delivered Via Quantum Dot-Labeled Nanoparticles and Activated and Genetically Modified LymphocytesGolfers against Cancer2006 - 2009

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Present Support

Principal Investigator $100000Novel Treatments for Malignant Brain Tumors and StrokePauline Sterne Wolff Memorial Foundation2001-2012

Principal Investigator $75000Apoptosis and Neurological InjuryPauline Sterne Wolff Memorial Foundation1999-2012

Principal Investigator $25000Apoptosis and Neurological InjuryGeorge A Robinson IV Foundation1999-2013

Principal Investigator $1000000Novel Technology for Treatment of Brain TumorsThe Veralan Foundation and The Methodist Hospital Foundation2010-2015

Principal Investigator $200000Neuroscience DevelopmentThe Taub Foundation and The Methodist Hospital Foundation2010-2013

Mentor $50000Targeting Mitochondria with a New Class of Glioma-SpecificChemotherapeutic AgentsAmerican Brain Tumor Association2011-2012

Kenneth R Peak Foundation $1000000000Director Brain and Pituitary Tumor Treatment Center

John S Dunn Foundation 300000000Two Endowed Chairs and Research FundingKenneth R Peak Brain and Pituitary Treatment Center

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

SCHOLARSHIPS

Sponsor -- American Heart Association $1500Medical Student Stroke Research Scholarship 1984

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship1994

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship 1996Sponsor -- Southern Medical Association $2500Medical Student Research Grant1997

Sponsor -- American Heart Association $2000Medical Student Research Scholarship1997

Sponsor -- Alpha Omega Alpha Honor Medical Society $3000Medical Student Research Scholarship2001

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

MULTICENTER CLINICAL TRIALS AS PRINCIPAL SITE INVESTIGATOR

1 Principal Site Investigator Treatment of Spinal Cord Injury with Naloxone or Methylprednisolone-The National Acute Spinal Cord Injury Trial-NASCIS II1984-1990

2 Principal Site Investigator Treatment of Alzheimerrsquos Disease with Intraventricular Bethanechol 1997-1989

3 Principal Site Investigator Treatment of Acute Spinal Cord Injury with Tirilizad Mesylate or Methylprednisolone The National Acute Spinal Cord Injury Trial-NACSIS III1991-1995

4 Principal Site Investigator A Randomized Double-Blind Vehicle-Controlled Trial of Tirilizad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage A Cooperative Study in North America1993-1997

5 Principal Site Investigator Cervical Spine Fusion Using Corraline Hydroxappatite as a Bone Substitute A Multicenter Trial 1998-2001

6 Principal Site Investigator A Prospective Randomized Controlled Cervical Fusion Study Using rhBMP-2 with the CORNERSTONE-SRtrade Allograft Ring and the ATLANTIStrade Anterior Cervical Plate 1999-2002

7 Principal Site Investigator Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma2003-2011

8 Principal Site Investigator Porous Tantalum Cervical Interbody Fusion Devices A Prospective Randomized Multi-Center Clinical Study2005-2011

9 Principal Site Investigator An Assessment of P-15 Bone Putty (Beta 2 Integrin Molecule) in Anterior Cervical Fusion with Instrumentation 2008-Present

10 Co-Principal Investigator DC VaxL for Treatment of Malignant Glioma A Multi-Center Vaccine Trial 2013-Present

11 Co-Principal Investigator Tocagen Gene Therapy for Malignant Glioma A Multi-Center Gene Therapy Trial 2013-Present

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

LOCAL CLINICAL TRIALS AS FIRST STEP TO NATIONAL MULTICENTER TRIALS

1 Co-Site Investigator An Assessment of Adoptive and Adaptive Immunotherapy for Glioblastoma using HER 2 targeting (In Collaboration with Cell and Gene Therapy- Using Patients from Multiple Centers) 2011-Present

2 Principal Site Investigator Assessment of DNA Damage in Glioblastoma For Individualized Chemotherapy 2010-Present

3 Principal Site Investigator Development of Individualized Tumor Microarrays to Assess Glioblastoma in partnership with American Tissue Collection Consortium 2013

4 Principal Site Investigator Genetic Alterations in Pituitary Adenomas In Partnership with Department of Pathology Houston Methodist Hospital

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

PRESENTATIONS

Cartography of periaqueductal gray stimulation in humans April 22 1980American Association of Neurological SurgeonsAnnual MeetingNew York New York

Whipples disease of the central nervous system Jan 22 1981Bay Area Infectious Disease ClubSan Francisco California

Transsphenoidal removal of growth hormone-secreting pituitary April 6 1981adenomas A review of 137 casesAmerican Association of Neurological SurgeonsAnnual MeetingBoston Massachusetts

Endogenous opioids and cerebral ischemia May 29 1981Department of Pharmacology Special SeminarUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Neurosurgical treatment of pituitary disease June 10 1981Neurosurgery Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

Opiates and cerebral ischemia Animal and human studies June 20 1981Department of Anesthetics Grand RoundsUniversity of Capetown Medical SchoolGroote Schuur HospitalCapetown Republic of South Africa

The opiate antagonist naloxone reverses the ischemic neurologic Oct 22 1981deficit produced by unilateral carotid ligation in gerbilsSociety for NeuroscienceAnnual MeetingLos Angeles California

Naloxone reversal of ischemic neurologic deficits Clinical and April 26 1982experimental studiesAnnual MeetingHonolulu Hawaii

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Naloxone reversal of ischemic neurologic deficits in baboons is not June 16 1982mediated by systemic effectsInternational Narcotics Research ConferenceAnnual MeetingFalmouth Massachusetts

Transsphenoidal treatment of non-neoplastic intrasellar cysts April 27 1983A report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

The role of the endogenous opioid system in the Oct 27 1983pathophysiology of cerebral ischemiaAmerican Academy of Neurological Surgeons27th Annual MeetingPebble Beach California

New concepts of cerebral ischemia Jan 9 1984Department of Neurological SurgeryBasic Science Conference University of Florida Medical CenterGainesville Florida

Endogenous opiates and cerebral ischemia Jan 11 1984Department of Neurological SurgeryHead Injury ConferenceMedical College of VirginiaRichmond Virginia

Treatment of experimental stroke with opiate antagonists Jan 18 1984Departments of Neurology and Neurosurgery Grand RoundsUniversity of Mississippi Medical CenterJackson Mississippi

Treatment of experimental focal ischemia with opiate agonists and April 10 1984antagonists Effects on neurologic function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Treatment of stroke with opiate antagonists - Effects of exogenous July 24 1984antagonists and dynorphin 1-13International Narcotics Research ConferenceAnnual Meeting Cambridge England

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Diagnosis and treatment of pituitary adenomas April 6 1985American Association of Neurological NursesHouston ChapterHouston Texas

Craniopharyngiomas April 23 1985American Association of Neurological SurgeonsAnnual MeetingAtlanta Georgia

Advances in treatment of Alzheimers disease and stroke Aug 29 1985Gallatin County Medical SocietyAnnual MeetingBozeman Deaconess HospitalBozeman Montana

Diagnosis and treatment of head injuries Aug 30 1985Weekly Clinical ConferenceBozeman Deaconess HospitalBozeman Montana

Lymphocytic adenohypophysitis Nov 20 1985Pituitary Society Monthly Meeting Park Plaza HospitalHouston Texas

Surgical management of craniopharyngiomas - A review of 74 cases Feb 27 1986Southern Neurosurgical SocietyAnnual Meeting Boca Raton Florida

Periaqueductal gray stimulation - A clinicopathological analysis March 11 1986International Society of Functional and Stereotactic SurgerySpecial MeetingGarmisch - Partenkirschen GermanyWeekly Clinical Conference

Management of Cushings disease April 21 1986Texas Medical AssociationAnnual MeetingHouston Texas

The sella is enlarged now what May 10 1986Symposium on Office Management of Common Pituitary DisordersDallas Texas

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Panel - management of prolactinomas May 10 1986Texas Medical AssociationAnnual MeetingSymposium on Office Management of Common Pituitary DisordersDallas Texas

Corticomotor evoked potentials in blunt spinal cord injury in the rat - June 16 1986Acute chronic and electrophysiologic studiesPurdue UniversityWest Lafayette Indiana

Treatment of experimental stroke with opiate antagonist WIN 44 441-3 July 10 1986Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Endogenous opioid peptides and cerebral ischemia Jan 22 1987Neuroscience SeminarDepartment of Neurobiology and AnatomyThe University of Texas Health Science CenterHouston Texas

Medical vs surgical therapy for prolactinomas May 16 1987Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersHouston Texas

Deep brain stimulation for pain control Nov 30 1987Materials Research Society1987 MeetingBoston Massachusetts

Pituitary tumors Surgical management including prolactinomas May 14 1988Texas Medical Association Annual MeetingSan Antonio Texas

Opioid peptides in focal cerebral ischemia in the cat Nov 17 1988Society for NeuroscienceAnnual MeetingToronto Canada

Bromocriptine and pituitary fibrosis Current status May 13 1989Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersFort Worth Texas

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Surgical management of craniopharyngioma May 12 1990Texas Medical AssociationAnnual MeetingSymposium on Pituitary DisordersCorpus Christi Texas

Treatment of subarachnoid hemorrhage June 30 1990Symposium on Cerebral IschemiaMiles PharmaceuticalsSan Antonio Texas

Advances in the treatment of spinal cord injury - The NASCIS II Study May 10 1991Texas Medical AssociationAnnual MeetingDallas Texas

Advances in microsurgery May 24 1990Galleria Chamber of CommerceDoubletree HotelHouston Texas

Challenges of pituitary surgery Oct 16 1991Pituitary Society of HoustonHouston Texas

Interview - Spinal Microsurgery Feb 21 1992Good Morning HoustonTV Channel 13Houston Texas

Brain Death Structure Biochemistry and Implications for the Clinician March 18 1992Fort Worth Neuroscience SocietyFort Worth Texas

Advances in microsurgery April 28 1992West Houston Business ClubHyatt HotelHouston Texas

Pituitary tumors Sept 17 1992American Association of Neuroscience NursesMarriott Medical Center HotelHouston Texas

ldquoResuscitation of central nervous system centerrdquo April 17 1993The Associated Alumni of the Mount Sinai Medical CenterScience Fiction or Scientific FactrdquoNew York New York

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

ldquoEndocrinologically active pituitary adenomasrdquo Oct 6 1993The Congress of Neurological SurgeonsAnnual Meeting Luncheon SeminarVancouver British Columbia

Brain tumors April 26 199418th Annual Review Course in Family MedicineBaylor College of MedicineHouston Texas

Evaluation and treatment of traumatic brain injury Jan 26 1995San Antonio Neurological SocietySan Antonio Texas

Brain tumors April 18 199519th Review Course in Family MedicineBaylor College of MedicineHouston TX

Treatment of traumatic brain injury - head injury and April 28 1995subarachnoid hemorrhageThird Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterWestlaco TX

Controversies in pituitary surgery Oct 19 1995Annual MeetingCongress of Neurological SurgeonsSan Francisco California

Advances in microsurgery of the brain March 24 1996Medical Symposium 1996Manama Bahrain

Advances in neurosurgery March 26 1996Annual Medical Conference of the Central Arab EmiratesAbu Dhabi United Arab Emirates

Brain tumors April 23 199620th Review Course in Family MedicineBaylor College of MedicineSheraton AstrodomeHouston Texas

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Cranio-cerebral injury April 25 1996Fourth Annual Rio Grande Valley Medical Education ConferenceKnapp Medical CenterMcAllen Texas

Neuroprotective effects of kappa opioids in focal cerebral ischemia April 30 1996and closed head injuryAnnual MeetingAmerican Association of Neurological SurgeonsMinneapolis Minnesota

K opioids Brain edema and ADH July 23 1996International Narcotics Research ConferenceLong Beach California

ldquoHead injury and subarachnoid hemorrhage Nov 5 1996New Methods and ManagementrdquoFall Surgery ConferenceCitizens Medical Center Victoria Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo March 20 1997North American Spine Society and theJapanese Spine SocietyMaui Hawaii

ldquoBrain tumors April 30 199721st Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoOutpatient lumbar microdiskectomy - A safe and effective procedurerdquo May 31 1997Annual Meeting of the Society of University NeurosurgeonsAnn Arbor MI

ldquoA novel approach for detection of apoptotic damagerdquo March 27 1998Society of University NeurosurgeonsMemphis Tennessee

ldquoApoptosis in CNS diseaserdquo July 17 1998Symposium Department of NeurosurgeryUniversity of California at San FranciscoSan Francisco California

ldquoApoptosisrdquo Oct 26 1998Review and Update in Neurobiology for NeurosurgeonsWoods Hole Massachusetts

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

ldquoSimultaneous detection of apoptotic and necrotic damage in brainrdquo Nov 11 1998Society for NeuroscienceAnnual MeetingLos Angeles California

ldquoNovel technologies for imaging apoptosisrdquo Jan 9 1999Visiting Professor LectureDepartment of NeurosurgeryState University of New York Health Science CenterSyracuse New York

ldquoSimultaneous detection of apoptotic and necrotic March 17 1999cell death in experimental strokerdquoSociety of University NeurosurgeonsMelbourne Australia

ldquoDetection of apoptotic DNA damage in live cells using March 19 1999fluorescence resonance energy transfer ndashdevelopment of molecular chameleonsrdquoSociety of University NeurosurgeonsPort Douglas Australia

ldquoLow back pain ndash when will surgery help (and what to do when it wonrsquot)rdquo April 23 199923rd Annual Family Medicine Review CourseBaylor College of MedicineSheraton AstrodomeHouston Texas

ldquoNeurosurgical treatment of neurofibromatosisrdquo Sept 11 1999The Texas Neurofibromatosis FoundationHouston Texas

ldquoA novel approach to analyze DNA damage in brain Oct 25 1999using vaccinia topoisomerase IrdquoSociety for NeuroscienceAnnual MeetingMiami Beach Florida

ldquoHead trauma seizure disorders amp neurologic assessmentrdquo May 12 20008th Annual Rio Grande Valley Medical Education ConferenceSouth Padre Island Texas

ldquoApoptosis in glial tumors Paradoxical results June 16 2000and new insightsrdquoSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

ldquoGlioblastomas Induce Apoptosis of Invading T-lymphocytesrdquo April 23 2001Annual MeetingAmerican Association of Neurological SurgeonsToronto Ontario Canada

ldquoApoptosis of T-lymphocytes Invading Glioblastoma - June 19 2001A Novel Demonstration of Tumor Counter Immune AttackrdquoSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft)rdquo Feb 19 2002American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

ldquoNovel Treatment for Glioblastoma Multiforme June 28 2002Using Targeted Delivery of Cellular ToxinsrdquoSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

ldquoNovel Treatment For Glioblastomas Using Nov 6 2002Targeted Delivery Of Cellular ToxinsrdquoSociety for NeuroscienceAnnual MeetingOrlando Florida

ldquoTargeted Therapy of Glioblastoma Using June 24 2003Selective Delivery of Toxins and ImmunogensrdquoSociety of University NeurosurgeonsAnnual MeetingNew York New York

ldquoNon-Viral Treatment of Glioblastomas Using Nov 7 2003Selective Targeted Intranuclear Delivery Of ToxinsrdquoCancer Center SymposiumThe Methodist HospitalHouston Texas

ldquoTargeted Therapy of Glioblastoma Using Nov 11 2003Immunogens Delivered via PolyethyleneiminerdquoSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

ldquoFailure of a Porous Tantalum Cervical Interbody Dec 10 2004Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyrdquoCervical Spine Research SocietyAnnual MeetingBoston Massachusetts

ldquoNanotechnology for Treatment of Neurosurgical Diseaserdquo March 19 2006Society of University NeurosurgeonsAnnual MeetingSan Diego California

ldquoB-Cells from Non-Verbal Autism Patients June 2 2006Have Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsrdquoInternational Meeting for Autism ResearchMontreal Canada

ldquoEndoscopic Neurosurgery and Minimally Invasive Feb 16 2007Brain SurgeryrdquoMethodist Neurological Institute Grand Rounds

ldquoQuantum Dotsrdquo May 6 2007Society of Neurological SurgeonsAnnual MeetingSan Francisco CA

ldquoAdvances in Endoscopic Neurosurgeryrdquo Sept 7 2007Methodist Neurological InstitutePost Graduate Course3rd Annual Advances in NeurologyHouston Texas

ldquoDecorin Mediated Decrease of Semaphorin Nov 6 2007and Neuropilin Expression in Glioma CellsrdquoSociety for NeuroscienceAnnual MeetingSan Diego CA

ldquoSemaphorins Control Tumor Migration and Invasion July 2 2008in Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetrdquoSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

ldquoWide Spread Panic Addressing March 23 2009Vaccine Safety and the Rise of AutismrdquoNational Association of Childrens HospitalsCreating Connections Conference Nashville TN

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

ldquoThe RNA Binding Protein HuR is a Primary Regulator Oct 27 2009of Growth in Gliomas - A Potential New Therapeutic TargetrdquoCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

ldquoImage Guidance Robotics and Dec 04 2009Virtual Surgery on CNS Malignanciesrdquo2nd International Computational Surgery SymposiumThe Methodist HospitalHouston TX

ldquoDetection of DNA Damage using Oligonucleotide Probes Jan 10 2010A New Approach to CNS DiseaserdquoThird Annual Texas Neurosurgery Residency Training Programs ConferenceSan Antonio Texas

ldquoImage Guided Neurosurgeryrdquo Feb 12 20105th Annual Neuroscience Nursing SymposiumThe Methodist HospitalHouston TX

ldquoChemotherapy Specific Nuclear and Mitochondrial DNA Damage- March 23 2010A Novel Approach to Personalized Chemotherapy Including Mitochondrial TargetingldquoSociety of University NeurosurgeonsMiami Florida

ldquoPrinciples of Neurosurgical Interventionrdquo March 31 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoManagement of Pituitary-Hypothalamic Diseaserdquo April 16 2010Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoStudies of Environmental Toxins in Cultured Lymphoblasts Oct 22 2010Of Children with Autism Their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

ldquoMP-MUS (I) A Novel MAO-B Activated Pro-Drug which Nov 06 2010Specifically Targets and Destroys Gliomal MitochondriarsquoAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

ldquoNovel Technology for Detection of DNA Damage- Nov 20 2010Application to Clinical Neuroscience and NeurosurgeryrdquoKeynote Speaker 5th International Conference of Neurosurgery Shanghai China

ldquoTargeting Glioblastoma with Chemotherapeutic Drugs Feb 05 2011A Nanotech ApproachrdquoFourth Annual Texas Neurosurgery ResidencyTraining Programs ConferenceHouston TX

ldquoIntroduction to Neurosurgeryrdquo March 30 2011Clinical Correlate Lectures1st Year Medical StudentsUniversity of Texas Health Science Center Medical SchoolHouston TX

ldquoHades Trident Therapy Application of Antibody Guided October 20 2011Nanosyringes in the Treatment of GlioblastomardquoAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Baskin David S November 15 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference CenterAustin TX

Baskin David SldquoHormone disruptors and Neurodevelopmental Disorders January 15 2012Are Pesticides the EtiologyFifth Annual Texas State Neurosurgery ConferenceHotel Zza ZzaHouston Texas

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Baskin David S March 19 2012ldquoHADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomardquoSociety of University NeurosurgeonsAtlanta Georgia

Baskin David S March 28 2012Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Baskin DS Livingston A Sharpe M October 20 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Targeted Mitochondrial Chemotherapy for Treatment of Cancer January 26 2013Sixth Annual Texas Neurosurgery Residency Training ProgramsConferenceHouston Texas

Neuroscience Anatomy and Technology February 8 2013A View of the FutureSenior Honors Neuroscience ClassSt Johnrsquos SchoolHouston Texas

Baskin David S February 15 2013Image Guided NeurosurgeryWisdom from the FieldNeuroscience Nursing ConferenceInnovations for Clinical Practice 2013Houston Texas

Baskin David S March 28 2013Introduction to Neurosurgery1st Year Medical Student ClassUniversity of Texas HoustonHouston Texas

Transsphenoidal Surgery-How I Do It April 28 2013Practical Clinic-Practical and Technical Aspects of Transsphenoidal SurgeryAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Pituitary Tumors April 29 2013Breakfast Seminar PanelistAmerican Association of Neurological Surgeons Annual MeetingNew Orleans Louisiana

Intracranial Pressure in SpacePanelist with Astronauts and Cosmonauts May 18 2013International Space Medicine Summit 2013Baker Institute for Public PolicyRice UniversityHouston Texas

Treatment of brain cancers with targeted nanosyringes September 26 2013for superselective delivery and inhibition of cellular pumpsAmerican Academy of NeurosurgeryNewport Beach California

21st Century Neurosurgery-Advances in Treatment for Brain Tumors January 23 2014Central Houston Rotary ClubHouston City ClubHouston Texas

Meeting and Grant Reviews February 20 2014Visual ImpairmentIntracranial PressureResearch and Clinical Advisory Panel National Aeronautics and Space Administration (NASA)

Grant Reviews March 14 2014NASANSBRI Grant Review Panel Visual Impairment Intracranial PressureNASA Research and Education Support ServicesCrescent City Virginia

NASA Medical Operations Group March 19 2014Intracranial Pressure in SpaceMedical Assessment of a Returning AstronautFrom the International Space Station including Lumbar Puncture

Novel Technology for Treatment of Brain Tumors April 1 2014Oncology Grand RoundsMethodist Cancer CenterHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

ldquoTranssphenoidal Surgery-How I Do Itrdquo April 5 2014Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

From the Lab to the Clinic New Concepts and Strategies October 25 2014For the Future Image Guided Therapy Seminar Houston Methodist Research InstituteHouston Texas

ldquoTranssphenoidal Surgery-How I Do Itrdquo May 2 2015Practical CourseTranssphenoidal SurgeryAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy May 31 2015as Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomaAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

ldquoNanosyringes and Mitochondrial Chemotherapy for Glioblastomardquo October 2 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoHSVtk and Radiation for Glioblastomardquo October 3 20152nd Annual Symposium on Image Guided Therapies Opportunities for a Translational Approach Across DisciplinesHouston Methodist Hospital Houston Texas

ldquoPersonalized Chemotherapy Treating Brain Cancers with Targeted November 20 2015Nanosyringesrdquo Society for Neuro-oncology Annual MeetingSan Antonio TexasNovember 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

ABSTRACTS

Baskin DS Mehler W Hosobuchi Y Richardson D Adams J Flitter M April 1980Cartography of periaqueductal gray stimulation in humansAnnual MeetingAmerican Association of Neurological SurgeonsNew York New York

Newfield P Litt L Baskin DS Boggan J Wilson CB March 1981Anesthetic considerations for acromegalic patientsAnnual MeetingSouthern Society of AnesthesiologistsNew Orleans Louisiana

Baskin DS Boggan JE Wilson CB April 1981Transsphenoidal removal of growth-hormone secreting pituitary adenomasA review of 137 casesAnnual MeetingAmerican Association of Neurological SurgeonsBoston Massachusetts

Hosobuchi Y Baskin DS Woo S Loh HH July 1981The opiate antagonists naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsInternational Narcotic ResearchAnnual MeetingKyoto Japan

Hosobuchi Y Baskin DS Woo S Loh HH Oct 1981The opiate antagonist naloxone reverses the ischemic neurologic deficit produced by unilateral carotid ligation in gerbilsSociety for Neuroscience11th Annual MeetingLos Angeles California

Baskin DS Hosobuchi Y Feb 1982Naloxone reversal of ischemic neurological deficits Federation of Western Societies of Neurological ScienceAnnual MeetingSan Diego California

Baskin DS Kieck CF Hosobuchi Y April 1982Naloxone reversal of ischemic neurological deficitsClinical and experimental studiesAmerican Association of Neurological SurgeonsAnnual MeetingHonolulu Hawaii

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Baskin DS Kieck CF Hosobuchi Y June 1982Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsInternational Narcotics Research ConferenceFalmouth Massachusetts

Levy RM Baskin DS Kaufman L Hosobuchi Y Nov 1982Serial changes in NMR images of acute experimental cerebral ischemiaTime course and effects of dexamethasone morphine and naloxoneSociety for Neurosciences12th Annual MeetingMinneapolis Minnesota

Baskin DS Wilson CB April 1983Transsphenoidal treatment of non-neoplastic intrasellar cystsA report of 38 casesAmerican Association of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Hosobuchi Y April 1984Treatment of experimental focal cerebral ischemia with opiate agonists andantagonists Effects on neurological function infarct size and survivalAmerican Association of Neurological SurgeonsAnnual MeetingSan Francisco California

Baskin DS Kuroda H Hosobuchi Y Lee NM July 1984Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13International Narcotic Research ConferenceCambridge England

Venger BH Baskin DS June 1985Isolated C-2 staphylococcal osteomyelitis without neurological deficitRocky Mountain Neurosurgical Society Inc20th Annual MeetingBanff Alberta Canada

Simpson RK Baskin DS Feb 1986Corticomotor evoked potentials in acute spinal cord injuryAmerican Association of Neurological Surgeons and Congress of Neurological SurgeonsAnnual MeetingJoint Section on Spinal DisordersSan Diego California

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Baskin DS Wilson CB Feb 1986Surgical management of craniopharyngiomas A review of 74 casesSouthern Neurosurgical SocietyAnnual MeetingBoca Raton Florida

Baskin DS Simpson RK June 1986Corticomotor evoked potentials in blunt spinal cord injury in the ratAcute chronic and electrophysiologic studiesInternational Symposium on Motor Evoked PotentialsPurdue UniversityWest Lafayette Indiana

Baskin DS Hosobuchi Y July 1986Treatment of experimental stroke with the opiate antagonists WIN 44441-3Effects on neurologic function infarct size and survivalInternational Narcotics Research ConferenceSan Francisco California

Baskin DS Dec 1986Pharmacology of acute spinal cord injury Restorative neurology and the comprehensive rehabilitation of the spinal cordinjured patientPost Graduate CourseBaylor College of MedicineHouston Texas

Baskin DS May 1987Medical versus surgical therapy for prolactinomasTexas Medical AssociationAnnual SessionHouston Texas

Simpson RK Baskin DS Sept 1987Electrophysiological characteristics of corticomotor evoked potentials in the ratAmerican College of SurgeonsSurgical ForumSan Francisco California

Swihart AA Pirozzolo FJ Baskin DS Appel SH Oct 1987Somatostatin and cognitive dysfunction in Alzheimers diseaseAmerican Neurological Association Annual MeetingSan Francisco California

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Hayman LA McCardle C Taber K Baskin DS et al Nov 1987The role of clot formation in MR of bloodRadiological Society of North AmericaAnnual Meeting

Baskin DS Wilson CB April 1988Surgical management of craniopharyngiomas A review of 74 casesCurrent Surgery 45148

Hayman LA McCardle C Taber K Baskin DS et al May 1988The role of clot formation in MR of bloodAmerican Society of Neuroradiology

Baskin DS Browning JL Nov 1988Opioid peptides in focal cerebral ischemia in the catSociety for NeuroscienceAnnual Meeting

Baskin DS May 1989Bromocriptine and pituitary fibrosis Current statusTexas Medical Association Annual Meeting

Goodman JC Baskin DS June 1989The neuropathological spectrum of angiolipomaAmerican Association of NeuropathlogyAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1989Effects of anesthetic agents and arterial PCO2 in focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS May 1990Surgical management of craniopharyngiomasTexas Medical AssociationAnnual Meeting

Browning JL Heizer ML Baskin DS Oct 1990Effects of physiological parameters on motor and sensory evoked potentialsSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1991Dynorphin A (1-13) improves outcome followingthree vessel occlusion in the catSociety for NeuroscienceAnnual Meeting

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Widmayer MA Browning JL Baskin DS Oct 1992U50488 reduces the severity of tissue damage in a rabbit model offocal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Browning JL Turner TD Widmayer MA Baskin DS Oct 1992The penetration of dynorphin 1-13 across the blood brain barrierSociety for NeuroscienceAnnual Meeting

Browning JL Widmayer MA Hoffman KK Baskin DS Oct 1993The effect of time after occlusion on injury volume in a rabbit modelof focal cerebral ischemiaSociety for NeuroscienceAnnual Meeting

Baskin DS Browning JL Widmayer MA Heizer M April 1994Kappa opioid agonists increase survival improve neurologicalfunction and reduce tissue damage and edema in focal cerebral ischemiaAmerican Association of Neurological SurgeonsAnnual MeetingSan Diego CA

Browning JL Turner TD Widmayer MA Baskin DS Nov 1994Kappa opioids and vasopressin (AVP)Society for NeuroscienceAnnual MeetingMiami Beach FL

Widmayer MA Browning JL Turner TD Baskin DS Nov 1994Multiple boluses of dynorphin improve outcome following focal cerebralischemia in the catSociety for NeuroscienceAnnual MeetingMiami Beach FL

Hoffman KK Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaStudies in the vasopressin (AVP) deficient ratSociety for NeuroscienceAnnual MeetingSan Diego CA

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Browning JL Widmayer MA Baskin DS Nov 1995Mechanism of kappa opioids in cerebral ischemiaReduction of cerebral edemaSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Robertson CS Browning JL Gopinath S Widmayer MA April 1996Neuroprotective effects of kappa opioids in focal cerebral ischemiaand closed head injuryAmerican Association of Neurological SurgeonsAnnual MeetingMinneapolis Minnesota

Baskin DS Widmayer MA Browning JL July 1996 opioids brain edema and ADHInternational Narcotics Research ConferenceLong Beach California

Widmayer MA Browning JL Keck JM Baskin DS Nov 1996Time course of edema development in the rabbit three vesselocclusion modelSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Browning JL Widmayer MA Nov 1996Dynorphin 1-13 crosses the blood-brain barrier followingcerebral ischemia in catsSociety for NeuroscienceAnnual MeetingWashington DC

Baskin DS Zhang YJ Saxe ME Feb 1997Outpatient lumbar microdiskectomy -A safe and effective procedureJoint Section on Disorders of the Spine and Peripheral NervesAnnual MeetingNewport Beach California

Baskin DS Zhang YJ Saxe ME March 1997Outpatient lumbar microdiskectomy -A safe and effective procedureNorth American Spine Society and theJapanese Spine Research SocietyMaui Hawaii

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Baskin DS Zhang YJ Saxe ME May 1997Outpatient lumbar microdiskectomy -A safe and effective procedureSociety of University NeurosurgeonsAnn Arbor Michigan

Baskin DS Zhang YJ Widmayer M Feb 1998c-Fos antisense oligonucleotide administration prior to cerebrovascular occlusion exacerbates tissue damageAmerican Heart Association - Joint Conference on Strokeand Cerebrovascular DiseaseOrlando Florida

Baskin DS Didenko V Boudreaux D March 1998A novel approach for detection of apoptotic damageSociety of University NeurosurgeonsMemphis Tennessee

Didenko V Baskin DS Boudreaux D April 1998Novel technology for the detection of apoptotic damageHouston Society for Engineering in Medicine and BiologyHouston Texas

Zhang YJ Widmayer MA Zhang BX Cui J Liu PK Baskin DS April 1998Suppression of ischemia-induced Fos expression by an antisenseoligonucleotide to c-fos mRNA leads to increased tissue damageAmerican Association of Neurological SurgeonsAnnual MeetingPhiladelphia Pennsylvania

Didenko VV Boudreaux DJ Widmayer MA Baskin DS Nov 1998Simultaneous detection of apoptotic and necrotic damage in brainSociety for NeuroscienceAnnual MeetingLos Angeles California

Baskin DS Boudreaux DJ Widmayer MA Didenko VV March 1999Simultaneous detection of apoptotic and necroticcell death in experimental strokeSociety of University NeurosurgeonsMelbourne Australia

Baskin DS Brizollara R Zhang BX Ngo H Didenko VV March 1999Detection of apoptotic DNA damage in live cells usingfluorescence resonance energy transfer ndash development of molecular chameleonsSociety of University NeurosurgeonsPort Douglas Australia

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Baskin DS Didenko VV Oct 1999A novel approach to analyze DNA damage in brainusing vaccinia topoisomerase ISociety for NeuroscienceAnnual MeetingMiami Beach Florida

Didenko VV Zhang B Ngo HN Baskin DS Oct 1999Detection of apoptotic DNA damage in live cells using fluorescenceresonance energy transfer - development of molecular chameleonsSociety for NeuroscienceAnnual MeetingMiami Beach Florida

Baskin DS Ngo H Frankel B Didenko VV June 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety of University NeurosurgeonsAnnual MeetingBoston Massachusetts

Baskin DS Ngo HN Didenko VV Nov 2000Apoptosis in glial tumors Paradoxical results and new insightsSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Didenko VV Ngo HN Baskin DS Nov 2000Switch from caspase 3-dependent to caspase 3-independentapoptosis in focal brain ischemiaSociety for NeuroscienceAnnual MeetingNew Orleans Louisiana

Baskin DS Minchew C Ngo H Didenko VV June 2001Apoptosis of T-lymphocytes invading glioblastoma - A novel demonstration of tumor counter immune attackSociety of University NeurosurgeonsAnnual MeetingPortland Oregon

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftNorth American Spine SocietyAnnual MeetingSeattle Washington

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Baskin DS Minchew C Ngo H Didenko VV Nov 2001Apoptosis of T-lymphocytes invading glioblastoma ndash A novel demonstration of tumor counter immune attackSociety for NeuroscienceAnnual MeetingSan Diego California

Didenko VV Ngo H Minchew C Boudreaux D Baskin DS Nov 2001Novel approach for selective visualization oflethally damaged cells in focal brain ischemiaSociety for NeuroscienceAnnual MeetingSan Diego California

Lynch J Baskin DS Ryan P Westmark R Bartolomei J Theodore N Sonntag V Nov 2001ACDFP with Cornerstone-SR allograft and plate rhBMP-2 vs autograftCervical Spine Research SocietyAnnual MeetingMonterey California

Baskin DS Ryan P Westmark R Lynch J Bartolomei J Theodore N Sonntag V Feb 2002ACDFP with Cornerstone-SR (Allograft and Plate rhBMP-2 vs Autograft) American Association of Neurological Surgeonsand Congress of Neurological SurgeonsSection on Disorders of the Spine and Peripheral NervesAnnual MeetingOrlando Florida

Baskin DS Widmayer MA Ngo H Didenko VV June 2002Novel Treatment for Glioblastoma MultiformeUsing Targeted Delivery of Cellular ToxinsSociety of University NeurosurgeonsAnnual MeetingChicago Illinois

Songer M Baskin DS Kabins M Reynolds A Zak P Oct 2002Prospective randomized comparison of Proosteon 200 Coralline Hydroxyapatite bone graft substitute vs iliac crest autografts in anterior cervical fusionsNorth American Spine SocietyAnnual MeetingMontreal Canada

Baskin DS Widmayer MA Ngo H Didenko VV Nov 2002Novel Treatment For Glioblastomas UsingTargeted Delivery Of Cellular ToxinsSociety for NeuroscienceAnnual MeetingOrlando FL

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Lowenthal B and the PROLONG Study Group Nov 2002PROLONG Preliminary Report of a New Outcomes Registryfor Patients Treated with GLIADEL Wafer Society for Neuro-OncologyAnnual MeetingSan Diego CA

Baskin DS Ngo H Widmayer MA Didenko VV June 2003Targeted Therapy of Glioblastoma using Selective Delivery of Toxins and ImmunogensSociety of University NeurosurgeonsAnnual MeetingNew York NY

Baskin DS Fewell K Ngo H Zhang B Widmayer M Didenko V Nov 2003Targeted Therapy of Glioblastoma UsingImmunogens Delivered via PolyethyleneimineSociety for NeuroscienceAnnual MeetingNew Orleans LA

Baskin DS Ngo HN Didenko VVThimerosal Induces DNA Breaks Caspase-3 Activation Membrane Oct 2004Damage and Cell Death in Cultured Human CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Traynelis V Dec 2004Failure of a Porous Tantalum Cervical Interbody Fusion Device Two Year Results from a Prospective Randomized Multi-Center Clinical StudyCervical Spine Research SocietyAnnual MeetingBoston MA

Baskin DS Ngo HN Didenko VV March 2006Nanotechnology for Treatment of Neurosurgical DiseaseSociety of University NeurosurgeonsAnnual MeetingSan Diego California

Baskin DS Minchew C Didenko VV June 2006B-Cells from Non-Verbal Autism PatientsHave Elevated Levels of Spontaneous ApoptosisCompared to Verbal Autism and Control PatientsInternational Meeting for Autism ResearchMontreal Canada

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Baskin DS Jeromin AJ May 2007Quantum DotsSociety of Neurological SurgeonsAnnual MeetingSan Francisco CA

Bournat JC Baskin DS Nov 2007Decorin Mediated Decrease of Semaphorinand Neuropilin Expression in Glioma CellsSociety for NeuroscienceAnnual MeetingSan Diego CA

Baskin DS Lopez S Bournat JC July 2008Semaphorins Control Tumor Migration and Invasionin Glioblastoma and Malignant Meningioma ndash A Novel New Therapeutic TargetSociety of University NeurosurgeonsAnnual MeetingSan Francisco CA

Chiocca EA Kaur B Hardcastle J Bell S Cavaliere R October 2009Lo S Badie B Portnow J Monterroso C Aguilar LKAguilar-Cordova E Baskin D Trask T New PPhase III Results of AdV-tk Gene Mediated CytotoxicImmunotherapy - Adjuvant to Standard Upfront Surgeryand Chemoradiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingNew Orleans LA

Voado E Moisi MD Dilorenzo DJ Holman PJ Zhang YJ October 2009Baskin DS Rose JE Grossman RGDecompressive Hemicraniectomy and Duraplasty for Ischemic StrokeCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin DS Bolognani F October 2009The RNA Binding Protein HuR is a Primary Regulatorof Growth in Gliomas - A Potential New Therapeutic TargetCongress of Neurological SurgeonsAnnual MeetingNew Orleans LA

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Baskin D Sharpe M March 2010Chemotherapy Specific Nuclear and Mitochondrial DNA Damage-A Novel Approach to Personalized Chemotherapy Including Mitochondrial Targeting Society of University NeurosurgeonsMiami Florida

Baskin DS October 2010Studies of Environmental Toxins in Cultured LymphoblastsOf Children with Autism their Siblings andExternal Controls-A Multifactorial AnalysisrdquoChildrenrsquos Environmental Health InstituteSixth Biennial Scientific SymposiumSeabrook TX

Baskin D Sharpe M November 2010MP-MUS (I) A Novel MAO-B Activated Pro-Drug whichSpecifically Targets and Destroys Gliomal MitochondriaAmerican Academy of Neurological SurgeryAnnual MeetingPebble Beach CA

Baskin DS November 2010Novel Technology for Detection of DNA Damage-Application to Clinical Neuroscience and NeurosurgeryFifth International Conference of Neurosurgery Shanghai China

Kasliwal MK Baskin DS Traynelis VD October 2011Failure of Porous Tantalum Cervical Interbody Fusion DevicesTwo-Year Results from a Prospective RandomizedMulti-Center Clinical StudyCongress of Neurological SurgeonsAnnual MeetingWashington DC

Baskin DS Marcano D Tour J Sharpe MA October 2011Hades Trident Therapy Application of Antibody GuidedNanosyringes in the Treatment of GlioblastomaAmerican Academy of Neurological SurgeryAnnual MeetingScottsdale AZ

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Chiocca1 EA Aguilar LKAguilar-Cordova E Manzanera AG November 2011Harney KR Portnow J Badie B Lesniak M BellS Ray-Chaudhuri AKaur B Hardcastle J Cavaliere R McGregor J Lo S Chakarvarti AGrecula J Newton H Trask TW Baskin DS New PZPhase 2 Study of Gene Mediated Cytotoxic Immunotherapy Adjuvantto Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaSociety for Neuro-OncologyAnnual MeetingOrange County CA

Baskin David S November 2011Mercury and Hormone Disruptors A Study of Autistic LymphocytesChildrens Health Environmental Contributors toDevelopmental and Intellectual DisabilitiesDell Childrenrsquos Medical Center of Central TexasSigne Auditorium Pat Hayes Conference Center4900 Mueller BlvdAustin TX 78723

Baskin David S Sharpe Martyn A Marcano Daniela C Berlin March 2012 Jacob M Tour James M HADES Antigen Targeted Superselective Nano-Syringes for the Treatment of GlioblastomaSociety of University NeurosurgeonsEmory UniversityAtlanta Georgia

Baskin DS Livingston A Sharpe M October 2012Novel Nanovector Nanosyringe Delivered Drug Pump Inhibitors (Cerebrus) Potentiate the Action of Nanovector-Delivered Chemotherapy (HADES) in Cultured Primary Human GlioblastomaAmerican Academy of Neurosurgery 74th Annual MeetingChathamCape Cod Massachusetts

Baskin DS Sharpe MA Treatment of Human Brain Cancers with Targeted September 2013Nanosyringes for Superselective Delivery and Inhibition Of Cellular Pumps American Academy of Neurosurgery 75th Annual MeetingNewport Beach California

Cykowski M Powell S Baskin DS Specificity of Immunohistochemical March 2014Markers of Differentiation in the Sellar Region Implications for the Diagnosis of Metastatic Carcinoma United States amp Canadian Academy of Pathology 103rd Annual Meeting

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo May 2015S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DSPortnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA ldquoPhase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy As Adjuvant to Surgical Resection for Newly Diagnosed Malignant GliomardquoAmerican Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Ahmed N Brawley V Diouf O Wakefield A Ashoori A Ghazi A May 2015Gerken C Yi J Liu H Rooney CM Dotti G Gee A Grossman RG Kew Y Baskin DS Zhang J New PHicks J Powell SZ Wels W Brenner MK Heslop HE Gottschalk SldquoA Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastomardquo American Society of Clinical Oncology Meeting Annual MeetingChicago Illinois

Joseph Landolfi Timothy Cloughesy Michael A Vogelbaum November 2015Santosh Kesari Steven N Kalkanis Jana Portnow Tom Mikkelsen J Bradley Elder David Baskin Alice Chu Andreas Niethammer Harry Gruber Charles Cobb Greg Foltz George Kaptain Manish K AghiOverall safety and efficacy in subjects with recurrent HGG treated acrossTwo Tocagen studies Prognostic Factors associated with survivalSociety for Neuro-Oncology Annual MeetingSan Antonio Texas

Sharpe MA Baskin DS Personalized Chemotherapy Treating Brain November 2015Cancers with Targeted Nanosyringes Society for Neuro-Oncology Annual MeetingSan Antonio Texas

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

PATENTS

Baskin DS Lam DMK United States Patent 4859674 Pyrazine in prevention and treatment of strokes August 22 1989

Didenko V Baskin DS Vaccinia Topoisomerases I Based Assays for Detection of Specific DNA Breaks United States Patent 6864058 Publication date May 13 2004

Martyn A Sharpe amp David S Baskin OTT201001 (2011) Provisional - Preparation of labeled gelatin slices to act as absolute standards (phantoms) for tissue slices (TMH)

Martyn A Sharpe amp David S Baskin OTT2010-22 (2011) Provisional - Chemotherapeutic compositions and methods for treating human gliomas (TMH)

Martyn A Sharpe amp David S Baskin (The Methodist Hospital) amp James Tour Jacob Berlin amp Daniela Marcano (Rice University) OTT201115 - The use of a nanotechnology based microinjection system to deliver drugs to antigen-specific cell types The treatment of primary Glioblastoma with SN-38 using anti-glial fibrillary acidic protein (GFAP) IgG as an example Patent submission in Progress TMH and Rice University

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

PUBLICATIONS

1 Baskin DS Klein SM Yang WC Sachdev VP Malis LI Traumatic epidural hematoma in shunt-dependent patients A report of two cases Surg Neurol 11135-139 1979

2 Baskin DS Wilson CB Pituitary tumors a guide for primary care physicians Compre Med Ther 612-21 1980

3 Hosobuchi Y Lamb S Baskin DS Tryptophan loading may reverse tolerance to opiate analgesics in humans A preliminary report Pain 9161 1980

4 Baskin DS Wilson CB Bromocriptine treatment of pituitary adenomas Neurosurgery 8741-744 1981

5 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurological deficits in man Lancet 2272-275 (August 8) 1981

6 Baskin DS Townsend JJ Wilson CB Isolated hypertrophic interstitial neuropathy of the trigeminal nerve associated with trigeminal neuralgia A previously undescribed entity J Neurosurg 55987-990 1981

7 Hosobuchi Y Baskin DS Woo S Loh HH Naloxone reverses induced ischemic neurologic deficit in gerbils In Takagi H (Ed) Advances in Endogenous and Exogenous Opioids Kodansha Press Tokyo 1981 pp353-355

8 Baskin DS Townsend JJ Wilson CB Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma A distinct pathologic entity J Neurosurg 56l48-l53 1982

9 Hosobuchi Y Baskin DS Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone Science 21569-71 1982

10 Baskin DS Hosobuchi Y Naloxone reversal of ischemic neurologic deficits in humans J Int Med 599-104 1982

11 Baskin DS Boggan JE Wilson CB Transsphenoidal microsurgical removal of growth hormone secreting pituitary adenomas A review of 137 cases J Neurosurg 56634-641 1982

12 Baskin DS Wilson CB CSF rhinorrhea after bromocriptine for prolactinomas New Engl J Med 306178 1982

13 Hosobuchi Y Baskin DS Woo SK Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans J Cerebral Blood Flow Metab 2 (Suppl 1) S98-S1001982

14 Baskin DS Wilson CB Brain tumors In Eiseman B Robinson WA Steele G (Eds) Follow-Up of the Cancer Patient Stratton New York 1982 pp15-18

15 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal of ischemic neurological deficits in baboons is not mediated by systemic effects Life Sci 312201-2204 1982

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

16 Hosobuchi Y Baskin DS Naloxone and ischemic neurologic deficits in the gerbil Is there an effect Science 218594 1982

17 Baskin DS Wilson CB Transsphenoidal treatment of intrasellar germinomas A report of two cases J Neurosurg 591063-2066 1983

18 Baskin DS Kieck CF Hosobuchi Y Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons Brain Res 290289-296 1984

19 Baskin DS Wilson CB Transsphenoidal treatment of non-neoplastic intrasellar cysts A report of 38 cases J Neurosurg 608-13 1984

20 Baskin DS Hosobuchi Y Naloxone and focal cerebral ischemia J Neurosurg 601328-1330 1984

21 Baskin DS Hosobuchi Y Loh HL Lee NM Dynorphin 1-13 improves survival in cats with focal cerebral ischemia Nature 312551-552 1984

22 Baskin DS Kuroda H Hosobuchi Y Lee NM Treatment of stroke with opiate antagonists - Effects of exogenous antagonists and dynorphin 1-13 Neuropeptides 5307-310 1985

23 Baskin DS Wilson CB Craniopharyngiomas In Krieger D and Bardin W (Eds) Current Therapy in Endocrinology and Metabolism BC Decker Inc Philadelphia pp 26-29 1985

24 Baskin DS Hosobuchi Y Grevel JC Treatment of experimental stroke with opiate antagonists Effects on neurological function infarct size and survival J Neurosurg 6499-103 1986

25 Baskin DS Mehler WR Hosobuchi Y Richardson DE Adams JE Flitter MA Autopsy analysis of the safety efficacy and cartography of electrical stimulation of the central gray in humans Brain Res 371231-236 1986

26 Venger BH Baskin DS Musher DM Brown EW Isolated C-2 osteomyelitis of hematogenous origin Case report and literature review Neurosurgery 18461-464 1986

27 Levy RM Gutin PH Baskin DS Pons VG Vancomycin penetration of a brain abscess A case report and review of the literature Neurosurgery 18632-636 1986

28 Baskin DS Wilson CB Surgical management of craniopharyngiomas A review of 74 cases J Neurosurg 6522-27 1986

29 Kuroda H Baskin DS Matsui T Loh HH Hosobuchi Y Lee NM Effects of dynorphin (1-13) on opiate binding and dopamine and GABA uptake in stroked cat brain Brain Res 37968-74 1986

30 Baskin DS Hosobuchi Y Opiate antagonists in experimental stroke J Neurosurg 65426-427 1986

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

31 Baskin DS Hosobuchi Y Treatment of experimental stroke with the opiate antagonist WIN 44441-3 Effects on neurologic function infarct size and survival National Institute of Drug Abuse Research Monograph Series Progress in Opioid Research Proceedings of the International Narcotics Research Conference US Department of Health pp531-534 1986

32 Simpson RK Baskin DS Corticomotor evoked potentials in acute and chronic blunt spinal cord injury in the rat Correlation with neurological outcome and histological damage Neurosurgery 20131-137 1987

33 Simpson RK Sirbasku DM Baskin DS Solitary brainstem metastasis Comparisons of x-ray computed tomography and magnetic resonance imaging to pathology J Neuro-Oncology 557-63 1987

34 Baskin DS Simpson RK Corticomotor and somatosensory evoked potential evaluation of acute spinal cord injury in the rat Neurosurgery 20871-877 1987

35 Pirozzolo FJ Baskin DS Swihart AA Appel SA Oral Tetrahydroaminoacridine in the treatment of senile dementia Alzheimers Type New Engl J Med 311003-1005 1987

36 Simpson RK Baskin DS Electrophysiological characteristics of the corticomotor evoked potential in the rat American College of Surgeons Surgical Forum 38503-505 1987

37 Baskin DS CNS Germinomas Recognition and management Contemp Neurosurgery 1151-6 1987

38 Simpson RK Goodman JC Rouah E Caraway N Baskin DS Late neuropathological consequences of strangulation Resuscitation 15171-185 1987

39 Simpson RK Baskin DS Early component changes in the corticomotor evoked potential following experimental stroke Stroke 181141-1147 1987

40 Simpson RK Baskin DS An animal model for studying spinal cord injury using corticomotor evoked potentials Neuro-Orthopedics 510-24 1988

41 Simpson RK Baskin DS Somatosensory influence on corticomotor evoked potentials J Spinal Disorders 1162-167 1988

42 Swihart AA Pirozzolo FJ Baskin DS Appel SH Somatostatin and cognitive dysfunction in Alzheimers disease Developmental Neuropsychology 5159-168 1989

43 Harbaugh RE Reeder TM Senter HJ Knopman DS Baskin DS Pirozzolo F Chui HC Shetter AG Bakay RAE Leblanc R Watson RT DeKosky ST Johnston JT Intracerebroventricular bethanechol infusion in Alzheimers disease Results of a collaborative double-blind study J Neurosurg 71481-486 1989

44 Hayman LA McArdle CB Taber KH Saleem A Kirkpatrick JB Baskin DS Lee HS Bryan RN MR imaging of hyperacute intracranial hemorrhage in the cat Amer J Neurorad 10681-686 1989

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

45 Pirozzolo FJ Inbody SB Simms PA Strittmatter WJ Baskin DS Neuropathological and neuropsychological changes in Alzheimers disease Relationship of biologic markers to behavioral markers Clinics in Geriatric Medicine 5425-440 1989

46 Mellion BT George RE Fischer DK Lidsky M Baskin DS Anterior sacral meningocele and tuberculous spondylitis of the sacrum in a patient with neurofibromatosis Case report and review of the literature J Neurofibromatosis 2299-308 1989

47 Goodman JC Baskin DS The neuropathological spectrum of angiolipoma J Neuropathol and Exp Neurol 48306 1989

48 Baskin DS Wilson CB Neurosurgical management of pituitary-hypothalamic disease Becker KB (Ed) Principles and Practice of Endocrinology and Metabolism JBLippincott Company Philadelphia 215-221 1990

49 Bracken MB Shepard MJ Collins WF Holford TR Young W Baskin DS Eisenberg HM Flamm E Leo-Summers L Maroon J Marshall LF Perot PL Piepmeier J Sonntag VKH Wagner FC Wilberger JE Winn HR A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury New Engl J Med 3221405-1411 1990

50 Goodman JC Baskin DS Autosomal dominant familial angiolipomatosis clinically mimicking neurofibromatosis A case report Neurofibromatosis 2326-331 1990

51 Simpson RK Azordegan PA Sirbasku DM Weathers SW Lidsky MD Baskin DS Rapid onset of quadriplegia from a pan-spinal epidural abscess Spine 161002-1005 1991

52 Simpson RK Baskin DS Dudley AH Bouge L Rothenberg F The influence of long-term indomethacin and nifedipine therapy on neurologic recovery from experimental spinal cord injury J Spinal Disorders 4420-427 1991

53 Bracken MB Shepard MJ Collins WF Holford TR Baskin DS Eisenberg HM Flamm E Leo-summers L Maroon JC Marshall LF Perot PH Piepmeier J Sonntag VKH Wagner FC Wilberger JL Winn HR Young W Methylprednisolone or naloxone treatment after acute spinal cord injury 1-year follow-up data J Neurosurg 7623-31 1992

54 Baskin DS Azordegan P Non-neurologic complications of spinal cord injury Piepmeier JM (ed) The Outcome Following Traumatic Spinal Cord Injury Futura Publishing Company New York 119-138 1992

55 Browning JL Heizer M Baskin DS motor and somatosensory evoked potentials Effects of temperature halothane anesthesia and arterial partial pressure of CO2 Anest Analg 74643-648 1992

56 Evans R Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders Oxford University Press New York 1992

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

57 Fischer DK Simpson RK Baskin DS Spinal spondylosis and disc disease In Evans R Baskin DS Yatsu FM (Eds) Prognosis in Neurological Disease Oxford University Press New York 335-351 1992

58 Bracken MB Shephard MJ Marshall LF Collins WF Perot PL Jr Holford TR Piepmeier J Baskin DS et al Neurosurgical forum J Neurosurg 77325-327 1992

59 Baskin DS Simpson RK Browning JL Dudley AW Rothenberg F Bouge L The effect of long term high dose naloxone infusion in experimental blunt spinal cord injury J Spinal Disorders 638-43 1993

60 Baskin DS Treatment of spinal cord injury In Grotta J (Ed) Management of the Acutely Ill Neurological Patient Churchill Livingstone New York 75-91 1993

61 Clarke SD Woo SY Butler B Denis WS Lu H Carpenter LS Chiu JK Thornby J Baskin DS Treatment of secretory pituitary adenoma with radiation therapy Radiology 188759-763 1993

62 Baskin DS Browning JL Widmayer MA Grossman RG Development of a model of Parkinsonrsquos disease in sheep using unilateral intracarotid injection of MPTP via slow continuous infusion Life Sciences 54471-479 1994

63 Widmayer MA Turner TD Browning JL Baskin DS U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia Mol Chem Neuropathol 22211-224 1994

64 Baskin DS Widmayer MA Browning JL Heizer ML Schmidt WK Evaluation of delayed treatment of focal cerebral ischemia with three selective k-opioid agonists in cats Stroke 252047-2054 1994

65 Muszynski CA Robertson DP Goodman JC Baskin DS Scalp hibernoma Case report and literature review Surgical Neurology 42343-345 1994

66 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 2nd Edition JB Lippincott Co Philadelphia 238-247 1995

67 Baskin DS Laws ER Post K In Hadley MN (Ed) Endocrinologically active pituitary microadenomas Perspectives in Neurological Surgery Quality Medical Publishing Inc St Louis MO Vol 6 No 1 pp 89-106 1995

68 Lee A Mawad M Baskin D Fatal subarachnoid hemorrhage from the rupture of a totally intracavernous carotid artery aneurysm Case report Neurosurgery 38596-599 1996

69 Rumana CS Baskin DS Brown-sequard syndrome produced by cervical disc herniation Case report and literature review Surgical Neurol 45359-361 1996

70 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma WB Saunders Company Philadelphia PA 276-299 1996

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

71 Browning JL Widmayer MA Hoffman KK Dudley AW Jr Baskin DS Time dependent variability of infarct size and hemispheric volume in experimental focal cerebral ischemia in the rabbit J Neurotrauma 13583-588 1996

72 Haley EC Jr Kassell NF Apperson-Hansen C Stat M Maile MH Alves WM Baskin DS and the participants A randomized double-blind vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage a cooperative study in North America J Neurosurg 86467-474 1997

73 Browning JL Heizer ML Widmayer MA Baskin DS Effects of halothane alpha-chloralose and pCO2 on injury volume and CSF B-endorphin levels in focal cerebral ischemia Mol Chem Neuropath 3129-42 1997

74 Turner TD Browning JL Widmayer MA Baskin DS Penetration of Dynorphin 1-13 across the blood brain barrier Neuropeptides 32141-149 1998

75 Lee A Sforza P Fard A Lepka M Baskin D Dauser R Pituitary Adenoma in Children J Neuro-ophthalmology 18102-105 1998

76 Berube NG Swanson XH Bertram MJ Kittle JD Didenko V Baskin DS Smith JR Pereira-Smith OM Cloning and characterization of CRF a novel C1q-related factor expressed in areas of the brain involved in motor function Mol Brain Res 63233-240 1999

77 Zhang Y Widmayer MA Zhang B Cui J Baskin DS Suppression of ischemia-induced fos expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage Brain Res 832112-117 1999

78 Baskin DS Browning JL Pirozzolo FJ Korporaal S Baskin JA Appel S Brain choline acetyltransferase and mental function in Alzheimers disease Arch Neurol 561121-1123 1999

79 Didenko V Boudreaux DJ Baskin DS Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligonucleotides Biotechniques 271130-1132 1999

80 Jones JA Hart S Baskin D Effenhauser R Johnson S Novas M Jennings R Davis J Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft recommendations for management and prevention Mil Med 1656-12 2000

81 Jackson R Baskin DS Prognosis of spinal cord injury In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 381-393 2000

82 Grundmeyer R Nelson EL Garber J Baskin DS Prognosis of spinal spondylosis and disc disease In Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 119-151 2000

83 Evans RE Baskin DS Yatsu F (Eds) Prognosis of Neurological Disorders 2nd Edition Oxford University Press New York NY 2000

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

84 Viswanath NS Rosenfield DB Baskin DS Wieber SJ Transient speech compromise following sublabial transsphenoidal surgery A case report and findings of a small preliminary study Ear Nose amp Throat 79286-289 2000

85 Baskin DS Neurosurgical management of pituitary-hypothalamic neoplasms In Becker KL (Ed) Principles and Practices of Endocrinology and Metabolism 3rd Edition Lippincott Williams and Wilkins Philadelphia 254-264 2001

86 Didenko VV Ngo H Baskin DS Apoptosis of T-lymphocytes invading glioblastoma a possible tumor defense mechanism J Neurosurgery 96580-584 2002

87 Didenko VV Ngo H Baskin DS In situ detection of double-strand DNA breaks with terminal 5rsquoOH groups In Didenko VV (ed) In Situ Detection of DNA Damage methods and protocols Humana Press Totowa NJ 2002

88 Didenko VV Ngo H Minchew C Boudreaux DJ Widmayer MA Baskin DS Caspase-3ndashdependent and independent apoptosis in focal brain ischemia Molec Med 8347-352 2002

89 Didenko VV Widmayer MA Ngo H Minchew C Boudreaux DJ Baskin DS Visualization of irreparable ischemic damage in brain by selective labeling of double strand bluntndashended DNA breaks Molec Med 8818-823 2002

90 Songer M Baskin DS Kabins M Reynolds A Zak P Prospective randomized comparison of ProOsteon 200 Coralline Hydroxyapatite bone graft substitute versus iliac crest autograft in anterior cervical fusions The Spine Journal Volume 2 Supplement Page 64 2002

91 Baskin DS Ryan P Sonntag V Westmark R Widmayer MA A Prospective randomized controlled cervical fusion study using rhBMP-2 with the CORNERSTONE-SRtrade allograft ring and the ATLANTIStrade anterior cervical plate Spine 281219-1225 2003

92 Didenko VV Ngo H James W Baskin DS Early necrotic DNA degradation presence of blunt ended DNA breaks 3rsquo and 5rsquo overhangs in apoptosis but only 5rsquo overhangs in early necrosis Am J Pathol 1621571-1578 2003

93 Baskin DS Ngo H Didenko VV Thimerosal Induces DNA breaks caspase-3 activation membrane damage and cell death in cultured human neurons and fibroblasts Toxicol Sci 74361-368 2003

94 Blaxill MF Baskin DS Spitzer WO Commentary Blaxill Baskin and Spitzer on Croen et al (2002) the changing prevalence of autism in CaliforniaJ Autism Dev Disord 33(2)223-226 2003

95 Didenko VV Minchew C Shuman S Baskin DS Semi-artificial fluorescent molecular machine for DNA damage detection Nano Letters 42461-2466 2004

96 Didenko VV and Baskin DS Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies Analytical Biochem 344168-173 2005

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

97 Didenko VV Moore V Baskin DS and Smalley RE Visualization of Individual Single-Walled Carbon Nanotubes by Fluorescent Polymer Wrapping Nano Letters 51563-1567 2005

98 Baskin DS Spinal Cord Injury In Evans RE (Ed) Neurology and Trauma 2nd Edition Oxford University Press New York New York 265-280 2006

99 Didenko VV Baskin DS Horseradish peroxidase-driven fluorescent labeling of nanotubes with quantum dots Biotechniques 40295-302 2006

100Teh BS Bloch C Paulino AC Shen S Hinckley L Baskin D Butler EB Amato R Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery Clinical Genitourinary Cancer 5334-337 2007

101Zahra H The BS Paulino A Yoshor D Trask T Baskin B Butler EB Stereotactic radiosurgery for trigeminal neuralgia utilizing the BrainLAB Novalis system Technology in Cancer Research amp Treatment 8407-412 2009

102Baskin DS Widmayer MA Sharpe MA Quantification and calibration of images in fluorescence microscopy Analytical Biochemistry 404118-126 2010

103Baskin DS Widmayer MA Sharpe MA Quantification of DNase type I ends DNase type II ends and modified bases using fluorescently labeled ddUTP terminal deoxynucleotidyl transferase and formamidopyrimidine-DNA glycosylase Biotechniques 49505-12 2010

104Widmayer MA Browning JL Gopinath SP Robertson CS Baskin DS Increased Intracranial Pressure is Associated with Elevated Cerebrospinal Fluid ADH Levels in Closed-Head Injury Neurological Research 321021-1026 2010

105Sharpe MA Widmayer MA Krishna C Baskin DS ddTUNEL CIAP-ddTUNEL and Fpg-ddTUNEL Quantification of 3rsquoOH and 3rsquoPO4 DNA ends and of Fpg-sensitive oxidizedacylated bases Biotechniques Protocol Guide 23-24 2011 doi10 2144000113546

106Rangel-Castilla L Baskin D Retromastoid Approach In Nader R Berta S Levy M (Eds) Neurosurgery Tricks of the Trade Thieme Medical Publishers New York 2011

107Chiocca EA Aguilar L Bell S Kaur B Hardcastle J Cavaliere R McGregor J Lo S Chaudhuri AR Chakravarti A Grecula J Newton H Harris K Grossman R Trask T Baskin D Monterroso C Manzanera A Aguilar-Cordova E and New P Phase IB Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology 293611-3619 2011

108 Bolognani F Gallani AI Sokol L Baskin DS Meisner-Kober N mRNA Stability Alterations Mediated by HuR are Necessary to Sustain the Fast Growth of Glioma Cells J Neurooncol 106(3)531-42 2012

109 Sharpe MA Marcano DC Berlin JM Widmayer MA Baskin DS and Tour J Antibody-targeted Nanovectors for the Treatment of Brain Cancers ACS Nano 6(4)3114-20 2012

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

110Sharpe MA Livingston AD and Baskin DS Thimerosal Derived Ethyl Mercury is a Mitochondrial Toxin in Human Astrocytes Organomercury Causes Oxidation and Breakage of mtDNA via Fenton Chemistry Journal of Toxicology Volume 2012 (2012) Article ID 373678

111Kasliwal MK Baskin DS Traynelis VC Failure of Porous Tantalum Cervical Interbody Fusion Devices Two-Year Results from a Prospective Randomized Multi-Center Clinical Study Journal of Spinal Disorders 26(5)239-45 2013

112 Sharpe MA Gist TL Baskin DS MD B-lymphocytes from a population of children with autism spectrum disorder and their unaffected siblings exhibit hypersensitivity to thimerosal Journal of Toxicology 2013 1-11 2013

113 Hegde M Corder A Chow KH Mukherjee M Ashoori A Kew Y Zhang Jonathan Baskin DS Merchant FA Brawley VS Byrd TT Krebs S Wu J Hao L Heslop HE Gottschalk S Yvon E Ahmed N Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma Molecular Therapy 21(11) 2087ndash2101 2013

114Barber S Castilla L Baskin DS Neuro-endoscopic resection of intraventricular tumors a systematic outcomes analysis Minimally Invasive Surgery Volume 2013 Article ID 898753 httpdxdoiorg1011552013898753 2013

115Sharpe MA Gist TL Baskin DS Alterations in sensitivity to estrogen dihydrotestosterone and xenogens in B-lymphocytes from children with autism spectrum disorder and their unaffected twinssiblings Journal of Toxicology 2013 Article ID 159810 httpdxdoiorg1011552013159810 2013

116 Staub B Castilla L Baskin DS Extraventricular Colloid Cyst with Invasion into the Skull Base Case Report and Literature Review World Neurosurgery 81(1)19-22 httpdxdoiorg101016jwneu201307080 2014

117 Staub BN Livingston AD Cheacutevez-Barrios P Baskin DS Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease Surg Neurol Int 5 33-38 2014

118Abdel-Baki M S Waguespack S Jones J Stapleton S Baskin DS Okcu M amp Okcu F Complete Resolution of Pituitary Carcinoma With a Chemotherapy Regimen Consisting of Carboplatin And Fluorouracil Case Report and Review of Literature Neuro-Oncology 16 136 2014

119 Barber SM Liebelt BD Baskin DS Incidence Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery Experience with 344 Consecutive Patients at a Single Tertiary Center Special Issue Hyponatremia Advances in Diagnosis and Management Journal of Clinical Medicine 3(4)1199-1219 2014 doi103390jcm3041199

120Baskin DS Pituitary Tumors in Emergency Approaches to Neurosurgical ConditionsAgrawal A Britz G (eds) ISBN 978-3-319-10692-2 (Print) 978-3-319-10693-9 Springer Verlag 2015

121 Sharpe MA Han J Baskin AM Baskin DS Design and Synthesis of a MAO-B-Selectively Activated Prodrug Based on MPTP A Mitochondria-Targeting Chemotherapeutic Agent for Treatment of Human Malignant Gliomas ChemMedChem 10 621-628 2015

122 Liebelt B Huang M Baskin DS Sellar Floor Reconstruction with the

Medporreg Implant vs Autologous Bone Following Transnasal Transsphenoidal surgery Outcome in 200 Consecutive Cases World Neurosurgery [Epub ahead of print] Feb 28 pii S1878-8750(15)00132-1 doi 101016jwneu201502025 2015

123 Evans RE Timm JS Baskin DS Expert Opinion A Left Frontal Secretory Meningioma Can Mimic Transformed Migraine With and Without Aura Headache 55 849-852 2015

124Scranton RS Baskin DS Impaired Pituitary Axes Following Traumatic Brain Injury Journal of Clinical Medicine 4 1463-1479 doi103390jcm4071463

125 Sharpe MA Livingston AD Gist TL Ghosh P Han JH Baskin DS Successful treatment of intracranial glioblastoma xenografts with a novel MAO-B-activated pro-drug EBioMedicine 2 Issue 9 1122ndash1132 2015

126Evans RW Timm JS Baskin DS Imaging the Patient with Migraine A Response Headache Early View online before print DOI 101111head12700 7 OCT 2015

127Huang M Steele W and Baskin DS Primary Central Nervous System Vasculitis Preceded by Lymphocytic Infundibulo-Panhypophysitis Case Report with a Review of the Literature Surgical Neurology International 6S407-13 2015 httpsurgicalneurologyintcomPrimary-central-nervous-system-vasculitis-preceded-by-granulomatous-hypophysitis-Case-report-with-a-review-of-the-literature

128Desai V Scranton R Baskin DS Intramedullary Spinal Cord Solitary Fibrous Tumor A Rare Clinical Entity Global Surgery 1 DOI 1015761GOS1000110 2015

129 Evans RW Timm JS Baskin DS Imaging the Patient With Migraine A Response Headache 55 1444-1445 2015 httponlinelibrarywileycomdoi101111head12700pdf

130Scranton R Evans RE Baskin DS Expert Opinions A Motion Simulator Ride Associated with Headache and Subdural Hematoma First Case Report Headache 55(10) pp1-7 2015 doi 101111head12717

131 Cykowski MD Takei H Baskin DS Rivera A Powell SZ Epithelial and organ-related marker expression in pituitary adenomas Neuropathology In Press 2015

132Sharpe MS Baskin DS Monoamine Oxidase B levels are Highly Expressed in Human Gliomas and are Correlated with the Expression of HiF-1α and Glial Fibrillary Acidic Protein Oncotarget In Press 2015

133 Barber S Teh B Baskin DS Fractionated Stereotactic Radiotherapy for Pituitary Adenomas Single-Center Experience with the BrainLAB Novalis System in 100 Consecutive Patients Neurosurgery In Press 2015

134 Huang Meng Baskin DS Fung S Glioblastoma Presenting with Pure Alexia and Palinopsia Involving the Left Inferior Occipital Gyrus and Visual Word Form Area Evaluated With fMRI and DTI Tractography World Neurosurgery In Press

135 Sharpe MA Gist T Samuel ELG Marcano DC Tour JM and Baskin DS Peptidyl Linked Nanovectors Deliver Chemotherapeutics and Drug Pump Inhibitors for Targeted Treatment of Cancer Neuro-Oncology Submitted 2015

136 Wheeler LA Manzanera AG Bell S Cavaliere R McGregor J Lo S Grecula J Newton H Badie B Lesniak M Trask TW Baskin DS Portnow J New PZ Aguilar LK Aguilar-Cordova E Chiocca EA Phase II Multicenter Study of Gene Mediated Cytotoxic Immunotherapy as Adjuvant to Surgical Resection for Newly Diagnosed Malignant Glioma Journal of Clinical Oncology Submitted 2015

IN PREPARATION

Barber S Baskin DS Central Line Infections in a Major Urban University Hospital Incidence Etiology and Recommendations for the Future Journal of the American Medical Association

Barber S Baskin DS Hyponatremia Secondary to Lumbar Drain Usage A Review of 400 CasesWorld Neurosurgery

Baskin DS Combined Endoscopic and Microscopic Transsphenoidal Surgery The Best of Both Worlds World Neurosurgery

Scranton RS Baskin DS Combined Hybrid Microscopic and Endoscopic Transsphenoidal Surgery Anatomy Instrumentation and Technique in Transsphenoidal Surgery Complication Avoidance and Management Techniques edited by Edward R Laws Aaron A Cohen-Gadol Theodore H Schwartz and Jason P Sheehan Springer Science

CURRENT RESEARCH INTERESTS

BASIC RESEARCHMolecular biology of pituitary and brain tumors including the role of apoptosisGenetic Defects in Pituitary TumorsThe treatment of brain edemaGene transfer therapy for acute and chronic neural injury and cancerDetection of apoptosis in vitro and in vivoNovel technology for detection of DNA damageNanotechnology for imaging gene modification and cancer treatmentImmunological interventions for malignant gliomasMolecular ImagingPathophysiology of AutismNovel Chemotherapeutic agents based on DNA damage targetsMitochondrial targeted ChemotherapyNanotechnology and Nanosyringes for Treatment of Cancer

CLINICAL RESEARCHNeuropeptide alterations in pituitary neoplasmsEndoscopic pituitary surgeryIntraoperative 3 Dimensional endoscopy for resection of pituitary and skull base tumorsAssessment of cervical spine fusion and instrumentation techniquesUse of bone substitutes and bone morphogenetic protein in spine reconstructionP15 B2 Integrin Molecule to enhance Spinal Fusion Technology development for minimally invasive neurosurgeryGene therapy for cancer and neural injuryRadiosurgery for brain and spine lesionsMinimally invasive brain surgeryTargeted immunotherapy for GlioblastomaTumor Vaccines for GlioblastomaMonoclonal antibodies for GlioblastomaGene therapy for GlioblastomaNovel Therapy for Glioblastoma

• EDUCATION
• Prior Support
• Present Support
• • SCHOLARSHIPS

CURRENT RESEARCH INTERESTS

BASIC RESEARCHMolecular biology of pituitary and brain tumors including the role of apoptosisGenetic Defects in Pituitary TumorsThe treatment of brain edemaGene transfer therapy for acute and chronic neural injury and cancerDetection of apoptosis in vitro and in vivoNovel technology for detection of DNA damageNanotechnology for imaging gene modification and cancer treatmentImmunological interventions for malignant gliomasMolecular ImagingPathophysiology of AutismNovel Chemotherapeutic agents based on DNA damage targetsMitochondrial targeted ChemotherapyNanotechnology and Nanosyringes for Treatment of Cancer

CLINICAL RESEARCHNeuropeptide alterations in pituitary neoplasmsEndoscopic pituitary surgeryIntraoperative 3 Dimensional endoscopy for resection of pituitary and skull base tumorsAssessment of cervical spine fusion and instrumentation techniquesUse of bone substitutes and bone morphogenetic protein in spine reconstructionP15 B2 Integrin Molecule to enhance Spinal Fusion Technology development for minimally invasive neurosurgeryGene therapy for cancer and neural injuryRadiosurgery for brain and spine lesionsMinimally invasive brain surgeryTargeted immunotherapy for GlioblastomaTumor Vaccines for GlioblastomaMonoclonal antibodies for GlioblastomaGene therapy for GlioblastomaNovel Therapy for Glioblastoma

• EDUCATION
• Prior Support
• Present Support
• • SCHOLARSHIPS